Language selection

Search

Patent 2369954 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2369954
(54) English Title: METHOD AND COMPOSITION FOR INHIBITING CORROSION IN AQUEOUS SYSTEMS
(54) French Title: PROCEDE ET COMPOSITION POUR INHIBER LA CORROSION DANS DES SYSTEMES AQUEUX
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • C23F 11/10 (2006.01)
  • C23F 11/08 (2006.01)
  • C23F 11/14 (2006.01)
(72) Inventors :
  • WHITAKER, KIM A. (United States of America)
  • CHENG, LONGCHUN (United States of America)
  • EHRHARDT, WILLIAM C. (United States of America)
  • STASNEY, DAWN (United States of America)
(73) Owners :
  • BETZDEARBORN INC. (United States of America)
(71) Applicants :
  • BETZDEARBORN INC. (United States of America)
(74) Agent: MOFFAT & CO.
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2000-05-02
(87) Open to Public Inspection: 2000-11-09
Examination requested: 2002-10-29
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2000/008750
(87) International Publication Number: WO2000/066810
(85) National Entry: 2001-10-31

(30) Application Priority Data:
Application No. Country/Territory Date
09/304,181 United States of America 1999-05-03
09/303,596 United States of America 1999-05-03
09/309,564 United States of America 1999-05-12
09/505,722 United States of America 2000-02-17

Abstracts

English Abstract




A method for controlling corrosion of metals, such as stainless steel, in
contact with an aqueous system which comprises introducing into said system at
least one tetrazolium compound of formula (I) wherein R1, R2 and R3 are
selected from the group consisting of lower alkyl, branched lower alkyl, aryl,
substituted aryl, alkylaryl, substituted alkylaryl and heterocyclic
substituted aryl, with the proviso that neither R1, R2, or R3 contain more
than 14 carbon atoms; and n is 1 or 2, such tetrazolium compound optionally
having associated water soluble ionic species if needed to obtain a neutral
charge.


French Abstract

L'invention concerne un procédé pour contrôler la corrosion de métaux tels que l'acier inoxydable en contact avec un système aqueux, qui consiste à introduire dans ledit système au moins un composé de tétrazolium correspondant à la formule (I) dans laquelle R1, R2 et R3 sont sélectionnés dans le groupe constitué d'alkyle inférieur, d'alkyle inférieur ramifié, d'aryle, d'aryle substitué, d'alkylaryle, d'alkylaryle substitué et d'aryle substitué hétérocyclique, à condition qu'aucun des R1, R2 et R3 ne contient plus de 14 atomes de carbone et que n est 1 ou 2, ces composés de tétrazolium possédant éventuellement des espèces ioniques hydrosolubles dans le cas où l'on voudrait obtenir une charge neutre.

Claims

Note: Claims are shown in the official language in which they were submitted.




We claim:

1. A composition for controlling the corrosion of metals in contact with an
aqueous system having a pH of about 6 or greater which comprises a combination
of:
(a) a tetrazolium compound of the formula:

Image

wherein R1, R2 and R3 are selected from the group consisting of lower alkyl,
branched lower
alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl and
heterocyclic substituted aryl,
with the proviso that neither R1, R2, or R3 contain more than 14 carbon atoms;
and n is 1 or 2,
such tetrazolium compound optionally having associated water soluble ionic
species if needed
to obtain a neutral charge, and
(b) at least one other aqueous system treatment material chosen so that the
material
does not substantially reduce the tetrazolium compound.
2. A composition as recited in claim 1 wherein said other aqueous system
treatment material is selected from the group consisting of inorganic
phosphates, borates,
nitrites, compounds that release a metal anion in water, 2,3-dihydroxybenzoic
acid, 1,10-
phenanthroline, polycarboxylates, akyl hydroxycarboxylic acids,
aminohydroxysuccinic acids,
carboxyamines, polyepoxysuccinic acids, modified polyepoxysuccinic acids,
monophosphonic
acids, diphosphonic acids, phosphonocarboxylic acids,
hydroxyphosphonocarboxylic acids,
aminophosphonic acids, phosphonomethylamine oxides, polymeric amine oxides,
polyetherpolyaminomethylene phosphonates, polyetherpolyamino-methylene
phosphonate N-
oxides, iminoakylenephosphonic acids, long chain fatty acid derivatives of
sarcosine;
telomeric, co-telomeric, polymeric, or copolymeric phosphorus-containing
carboxylates, alkali
metal silicates, monofluorophosphate, amines, diamines, alkanolamines, ether
amines, fatty
amines and diamines, quaternized amines, oxyalkylated amines, akyl pyridines,
tetrazoles,
imidazoline and substituted imidazolines, amidoamines, polyamines,
polyakylenepolyamines,

-43-


alkyl derivatives of benzene sulfonic acid, benzoates and substituted
benzoates,
aminobenzoates, salicylates, dimer-trimer acids, petroleum oxidates,
borogluconates; lignins,
lignosulfonates, tannins; straight chain C5-C11 monocarboxylates and C4-C15
.alpha.,.omega.-
dicarboxylates; amine salts of carboxylic acids and mercaptocarboxylic acids,
amino acids,
polyamino acids, hydroxyether acids and related lactone compounds, N-
acyliminodiacetic
acids; triazine di- and tri-carboxylic acis, phospho- and phosphate esters;
and
monofluorophosphates; water soluble salts thereof, and mixtures thereof.
3. A composition as recited in claim 1 wherein said tetrazolium
compound is selected from the group consisting of the water soluble salts of
Nitro Blue
Tetrazolium (2,2'-Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-dimethoxy-4,4'-
biphenylene]
ditetrazolium), Distyryl Nitroblue Tetrazolium (2,2'-Di-p-nitrophenyl-5,5'-
distyryl-3,3'-[3,3'-
dimethoxy-4,4'-biphenylene] ditetrazolium), Tetranitro Blue Tetrazolium (3,3'-
(3,3'-
Dimethoxy-4,4'-biphenylene)-bis-[2,5-p-nitrophenyl-2H-tetrazolium) and
Iodonitro
Tetrazolium (2-(4-lodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium).
4. A composition as recited in claim 2 wherein said tetrazolium compound is
selected from the group consisting of the water soluble salts of Nitro Blue
Tetrazolium (2,2'-
Di-p-nitrophenyl-5,5'-distyryl-3-,3'-[3,3'-dimethoxy-4,4'-biphenylene]
ditetrazolium),
Distyryl Nitroblue Tetrazolium (2,2'-Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-
dimethoxy-
4,4'-biphenylene] ditetrazolium), Tetranitro Blue Tetrazolium (3,3'-(3,3'-
Dimethoxy-4,4'-
biphenylene)-bis-[2,5-p-nitrophenyl-2H-tetrazolium) and Iodonitro Tetrazolium
(2-(4-lodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium).
5. A composition as recited in claim 1 wherein said water soluble ionic
species
are anions selected from the group consisting of halogens, nitrates, nitrites,
carbonates,
bicarbonates, sulfates, phosphates, and transition metal oxygenates.
6. A composition as recited in claim 5 wherein said halogens are selected from
the
group consisting of chlorides, fluorides, bromides and iodides.
7. A composition as recited in claim 6 wherein said halogen is chloride.
8. A composition as recited in claim 5 wherein said transition metal oxygenate
is
selected from the group consisting of molybdate, chromate, and tungstate.
9. A composition as recited in claim 8 wherein said transition metal oxygenate
is
molybdate.
-44-


10. A composition as recited in claim 2 wherein said inorganic phosphates are
orthophosphates, polyphosphates, water soluble salts thereof and mixtures
thereof.
11. A composition as recited in claim 2 wherein said inorganic phosphates are
a
mixture of orthophosphoric acid and pyrophosphoric acid or the water-soluble
salts thereof.
12. A composition as recited in claim 2 wherein said borate is a water-soluble
borate selected from the group consisting of tetraborates, metaborates, and
orthoborates.
13. A composition as recited in claim 12 wherein said water-soluble borate is
sodium tetraborate or a hydrate of sodium tetraborate.
14. A composition as recited in claim 2 wherein said nitrite is sodium
nitrite.
15. A composition as recited in claim 2 wherein the metal anion releasing
compounds are selected from the group consisting of the water soluble salts of
molybdate,
tungstate, vanadate, metavanadate, and chromate.
16. A composition as recited in claim 15 wherein the water soluble salt of a
molybdate is sodium molybdate or a hydrate of sodium molybdate.
17. A composition as recited in claim 2 wherein said polycarboxylates comprise
aliphatic compounds containing between about 4 and about 20 carbon atoms which
are
multiply substituted with carboxylate groups or water soluble salts thereof.
18. A composition as recited in claim 17 wherein said polycarboxylate is
1,2,3,4-
butanetetracarboxylic acid.
19. A composition as recited in claim 2 wherein said polycarboxylate is a
homopolymer obtained from the polymerization of an ethylenically unsaturated
monomer
containing one or more carboxyl groups.
20. A composition as recited in claim 19 wherein said homopolymer is
polyacrylic
acid or its water soluble salts.
21. A composition as recited in claim 19 wherein said homopolymer is
polymaleic
acid or its water soluble salts.
22. A composition as recited in claim 19 wherein said homopolymer is
polymaleic
anhydride or its water soluble salts.
23. A composition as recited in claim 2 wherein said polycarboxylate is a
copolymer obtained from the polymerization of two or more different
ethylenically
unsaturated monomers, each of said monomers containing one or more carboxyl
groups.
24. A composition as recited in claim 2 wherein said alkyl hydroxycarboxylic
acid
has the generalized formula




HOOC -(R B1)a -( R B2)b -(R B3)c - R B4
where a, b, and c are integers from 0 to 6 and (a+b+c)>0 where R B1, R B2, R
B3 comprise C=O or
CYZ, where Y and Z are separately selected from the group of H, OH, CHO, COON,
CH3,
CH2(OH), CH(OH)2, CH2(COOH), CH(OH)COOH, CH2(CHO) and CH(OH)CHO, so selected
that the molecule has a minimum of one OH group when written in its fully
hydrated form and
R B4 is either H or COOH, including the various stereoisomers and chemically
equivalent
cyclic, dehydrated, and hydrated forms of these acids and hydrolyzable esters
and acetals that
form the above compounds in water or the water soluble salts of such alkyl
hydroxycarboxylic
acids.
25. ~A composition as recited in claim 24 wherein said akyl
hydroxycarboxylic acid is chosen from the group consisting of tartaric acid,
mesotartaric acid,
citric acid, gluconic acid, glucoheptonic acid, ketomalonic acid, saccharic
acid and the water
soluble salts thereof.

26. ~A composition as recited in claim 2 wherein the said other aqueous
system treatment materials is a mixture of orthophosphoric acid or its water-
soluble salts and
at least one alkyl hydroxycarboxylic acid having the generalized formula
HOOC -(R B1)a -(R B2)b -(R B3)c -R B4
where a, b, and c are integers from 0 to 6 and (a+b+c)>p where R B1, R B2, R
B3 comprise C=O or
CYZ, where Y and Z are separately selected from the group of H, OH, CHO, COOH,
CH3,
CH2(OH), CH(OH)2, CH2(COOH), CH(OH)COOH, CH2(CHO) and CH(OH)CHO, so selected
that the molecule has a minimum of one OH group when written in its fully
hydrated form and
R B4 is either H or COOH, including the various stereoisomers and chemically
equivalent
cyclic, dehydrated, and hydrated forms of these acids and hydrolyzable esters
and acetals that
form the above compounds in water or the water soluble salts of such alkyl
hydroxycarboxylic
acids, and the water soluble salts thereof.

27. A composition as recited in claim 26 wherein the hydroxycarboxylic acid is
selected from the group consisting of tartaric acid, mesotartaric acid, citric
acid, gluonic acid,
glucoheptonic acid, ketomalonic acid, saccharic acid and the water soluble
salts thereof.

28. A composition as recited in claim 2 wherein said aminohydroxysuccinic acid
has the generalized formula

-46-




Image
wherein R C1 is H or C1 to C4 alkyl, optionally substituted with optionally
substituted with -OH,
-CO2H, -SO3H, or phenyl, C4 to C7 cycloalkyl, or phenyl which is optionally
substituted with
-OH or -CO2H, and R C2 is H, C1 to C6 alkyl, optionally substituted with -OH
or -CO2H
(specifically including the moiety -CH(CO2H)CH(OH)(CO2H)); and
Image
wherein R C2 is as above, and Z C is selected from the group consisting of
i)- (CH2)k wherein k is an integer from 2 to 10,
ii) -(CH2) 2 -X C -(CH2)2 wherein X C is -O-, -S-, -NR C3 , wherein R C3 is
selected from the
group consisting of H, C1 to C6 alkyl, hydroxyalkyl, carboxyalkyl, acyl, and -
C(O)OR C4
wherein R C4 is selected from the group consisting of C1 to C6 alkyl or benzyl
and a residue
having the general formula:
Image
wherein R C2 is as above,
iii) a residue having the generalized formula

-47-



Image

wherein Y is H, C1 to C6 alkyl, alkoxy, halogen, - CO2H, or - SO3H, m is
independently 0 or 1,
and p is 1 or 2, and
iv) a residue having the generalized formula:
Image
wherein R C5 and R C6 are independently H or C1 to C6 alkyl, Q is H or C1 to
C6 alkyl, s is 0, 1 or
2, t is independently 0, 1, 2, or 3, q is 0, 1, 2, or 3, and r is 1 or 2 or
water soluble salts thereof.

29. The composition as recited in claim 28 wherein the aminohydroxysuccinic
acid
is selected from the group consisting of iminodi(2-hydroxysuccinic acid), N,
N'-Bis(2-
hydroxysuccinyl)-1,6-hexanediamine, N,N'-Bis(2-hydroxysuccinyl)-m-
xylylenediamine, and
the water-soluble salts thereof.

30. A composition as recited in claim 2 wherein said other aqueous system
treatment material is a mixture of orthophosphoric acid or its water-soluble
salts and at least
one aminohydroxysuccinic acid wherein said aminohydroxysuccinic acid has the
generalized
formula
Image
wherein R C1 is H or C1 to C4 alkyl, optionally substituted with optionally
substituted with -OH,
-CO2H, -SO3H, or phenyl, C4 to C7 cycloalkyl, or phenyl which is optionally
substituted with
-OH or -CO2H, and R C2 is H, C1 to C6 alkyl, optionally substituted with -OH
or -CO2H
(specifically including the moiety -CH(CO2H)CH(OH)(CO2H)); and

-48-



Image

wherein R C2 is as above, and Z C is selected from the group consisting of
i)- (CH2) k - wherein k is an integer from 2 to 10,
ii) -(CH2)2 -X C-(CH2)2 wherein X C is -O-, -S-, -NR C3, wherein R C3 is
selected from the
group consisting of H, C1 to C6 alkyl, hydroxyalkyl, carboxyalkyl, acyl, and -
C(O)OR C4
wherein R C4 is selected from the group consisting of C1 to C6 alkyl or benzyl
and a residue
having the general formula:
Image
wherein R C2 is as above,
iii) a residue having the generalized formula
Image
wherein Y is H, C1 to C6 alkyl, alkoxy, halogen, - CO2H, or - SO3H, m is
independently 0 or 1,
and p is 1 or 2, and
iv) a residue having the generalized formula:

-49-



Image

wherein R C5 and R C6 are independently H or C1 to C6 alkyl, Q is H or C1 to
C6 alkyl, s is 0, 1 or
2, t is independently 0, 1, 2, or 3, q is 0, 1, 2, or 3, and r is 1 or 2 or
water soluble salts thereof.

31. A composition as recited in claim 30 wherein the aminohydroxysuccinic acid
is
selected from the group consisting of iminodi(2-hydroxysuccinic acid), N, N'-
Bis(2-
hydroxysuccinyl)-1,6-hexanediamine, N,N'-Bis(2-hydroxysuccinyl)-m-
xylylenediamine, and
the water-soluble salts thereof.

32. A composition as recited in claim 2 wherein the polyepoxysuccinic acid has
the
generalized formula
Image
where 1 ranges from about 2 to about 50, M T is hydrogen or a water soluble
cation and R T is
hydrogen, C1-4 alkyl or C1-4 substituted alkyl, or water soluble salts
thereof.

33. A composition as recited in claim 32 wherein R T is hydrogen and 1 ranges
from
about 2 to about 10.

34. A composition as recited in claim 32 wherein R T is hydrogen and 1 is from
about 4 to about 7.

35. A composition as recited in claim 2 wherein the said other aqueous system
treatment material is a mixture of orthophosphoric acid or its water-soluble
salts and a
polyepoxysuccinic acid having the generalized formula
Image
-50-



where 1 ranges from about 2 to about 50, M T is hydrogen or a water soluble
cation and R T is
hydrogen, C1-4 alkyl or C1-4 substituted alkyl, or water soluble salts
thereof.

36. A composition as recited in claim 35 wherein said polyepoxysuccinic acid
has
R T as hydrogen and 1 is from about 2 to about 10.

37. A composition as recited in claim 35 wherein said polyepoxysuccinic acid
has
R T as hydrogen and 1 is from about 4 to about 7.

38. A composition as recited in claim 2 wherein the modified polyepoxysuccinic
acid has the generalized formula
Image
wherein R D1, when present, is H, a substituted or non-substituted alkyl or
aryl moiety having a
carbon chain up to the length where solubility in aqueous solution is lost, or
a repeat unit
obtained after polymerization of an ethylenically unsaturated compound; R D2
and R D3 each
independently are H, C1 to C4 alkyl or C1 to C4 substituted alkyl; Z D is O,
S, NH, or NR D1,
where R D1 is as described above, n is a positive integer greater than 1; f is
a positive integer;
and M D is H, a water soluble cation, or a non-substituted lower alkyl group
having from 1 to 3
carbon atoms (when R D1 is not present, Z D may be M D O3S, where M D is as
described above).

39. The composition as recited in claim 38 wherein R D1 is the meta-xylylene
moiety (meta-CH2-C6H4-CH2-), R D2 and R D3 are both H, Z D is -NH, M D is Na
or H, and f=2,
and u is a positive integer greater than 1.

40. A composition as recited in claim 2 wherein said monophosphonic acid has
the
generalized formula

-51-



Image
wherein R F is a C1 to C12 straight or branched chain alkyl residue, a C2 to
C12 straight or
branched chain alkenyl residue, a C5 to C12 cycloalkyl residue, a C6 to C10
aryl residue, or a C7
to C12 aralkyl residue, and where R F may additionally be singly or multiply
substituted with
groups independently selected from the group consisting of hydroxyl, amino,
and halogen, or
the water soluble salts thereof.

41. A composition as recited in claim 2 wherein said diphosphonic acid has the
generalized formula
Image
wherein R K is a C1 to C12 straight or branched chain alkylene residue, a C2
to C12 straight or
branched chain alkenylene residue, a C5 to C12 cycloalkylene residue, a C6 to
C10 arylene
residue, or a C7 to C12 aralkylene residue where R K may additionally be
singly or multiply
substituted with groups independently selected from the group consisting of
hydroxyl, amino,
and halogen, or the water soluble salts thereof.

42. A composition as recited in claim 41 wherein said diphosphonic acid is 1-
hydroxyethane-1,1-diphosphonic acid or the water soluble salts thereof.

43. A composition as recited in claim 2 wherein said phosphonocarboxylic acid
has the
generalized formulas
Image
-52-



Image
where R H1 is H, alkyl, alkenyl, or alkinyl radical having 1 to 4 carbon
atoms, an aryl,
cycloalkyl, or aralkyl radical, or the radical selected from the following:
Image
where R H2 is H, alkyl radical of 1 to 4 carbon atoms, or a carboxyl radical;
and X H is
Image
selected from the following:
and where the -PO3H2 group is the phosphono group
Image
or the water-soluble salts thereof.

44. A composition as recited in claim 43 wherein said phosphonocarboxylic acid
is 2-phosphonobutane-1,2,4-tricarboxylic acid or the water soluble salts
thereof.

-53-



45. A composition as recited in claim 2 wherein said
hydroxyphosphonocarboxylic
acid has the generalized formula
Image
wherein R E is H, a C1 to C12 straight or branched chain alkyl residue, a C2
to C12 straight or
branched chain alkenyl residue, a C5 to C12 cycloalkyl residue, a C6 to C10
aryl residue, or a C7
to C12 aralkyl residue, X E is an optional group, which when present is a C1
to C10 straight or
branched chain alkylene residue, a C2 to C10 straight or branched chain
alkenylene residue, or a
C6 to C10 arylene residue or water soluble salts thereof.

46. A composition as recited in claim 45 wherein said
hydroxyphosphonocarboxylic acid is 2-hydroxy-phosphonoacetic acid or the water
soluble
salts thereof.

47. A composition as recited in claim 2 wherein said aminophosphonic acid has
the
generalized formula
Image
where R G2 is a lower alkylene having from about one to about four carbon
atoms, or an amine,
hydroxy, or halogen substituted lower alkylene; R G3 is R G2 - PO3H2, H, OH,
amino, substituted
amino, or R F, where R F is a C1 to C12 straight or branched chain alkyl
residue, a C2 to C12
straight or branched chain alkenyl residue, a C5 to C12 cycloalkyl residue, a
C6 to C10 aryl
residue, or a C7 to C12 aralkyl residue, and where R F may additionally be
singly or multiply
substituted with groups independently selected from the group consisting of
hydroxyl, amino,
and halogen, R G4 is R G3 or the group represented by the generalized formula:

-54-



Image
where R G5 and R G6 are each independently selected from the group consisting
of H, OH,
amino, substituted amino, and R F as previously defined; R G7 is R G5, R G6,
or the group R G2 -
PO3H2 with R G2 as previously defined; v is an integer from 1 to about 15; and
w is an integer
from 1 through about 14 or water soluble salts thereof.

48. A composition as recited in claim 47 wherein said aminophosphonic acid is
diethylenetriamine penta(methylenephosphonic acid) or the water soluble salts
thereof.

49. A composition as recited in claim 2 wherein said phosphonomethyl amine
oxide has
the generalized formula
Image
wherein either R A1 is selected from the group consisting of hydrocarbyl, and
hydroxy-
substituted, alkoxy-substituted, carboxyl-substituted and sulfonyl-substituted
hydrocarbyl; and
R A2 is selected from the group consisting of hydrocarbyl, and hydroxy-
substituted, alkoxy-
substituted, carboxyl-substituted and sulfonyl-substituted hydrocarbyl, -
CH2PO3H2, and
Image
-55-




or R A1 and R A2 together form an alicyclic ring having 3 to 5 carbon atoms in
the ring or a
water-soluble salt of said phosphonomethyl amine oxide, wherein said
hydrocarbyl includes
alkyl, aryl, and alkaryl groups which do not render the amine oxide insoluble
in water.

50. A composition as recited in claim 49 wherein said phosphonomethyl amine
oxide is
N,N-bis-phosphonomethylethanolamine N-oxide or the water soluble salts
thereof.

51. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
an oligomer, polymer, co-oligomer, or copolymer obtained from the
polymerization of one or
more unsaturated monomers in the presence of a phosphorus containing compound,
said
monomers containing one or more carboxyl groups or containing one or more
groups that
have been transformed after polymerization into carboxyl groups, and in which
the resulting
phosphorus containing carboxylate contains phosphorus incorporations that are
predominantly
or exclusively present as end-type phosphino species or the water soluble
salts thereof.

52. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
an oligomer, polymer, co-oligomer, or copolymer obtained from the
polymerization of one or
more unsaturated monomers in the presence of a phosphorus containing compound,
said
monomers containing one or more carboxyl groups or containing one or more
groups that
have been transformed after polymerization into carboxyl groups, and in which
the resulting
phosphorus containing carboxylate contains phosphorus incorporations that are
predominantly
or exclusively present as phosphono species or the water soluble salts
thereof.

53. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
an oligomer, polymer, co-oligomer, or copolymer obtained from the
polymerization of one or
more unsaturated monomers in the presence of a phosphorus containing compound,
said
monomers containing one or more carboxyl groups or containing one or more
groups that
have been transformed after polymerization into carboxyl groups, and in which
the resulting
phosphorus-containing carboxylate contains phosphorus incorporations that are
predominantly
or exclusively present as dialkylphosphino species or the water soluble salts
thereof.

54. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
an oligomer, polymer, co-oligomer, or copolymer obtained from the
polymerization of one or
more unsaturated monomers in the presence of a phosphorus containing compound,
said
monomers containing one or more carboxyl groups or containing one or more
groups that
have been transformed after polymerization into carboxyl groups, and in which
the resulting
phosphorus-containing carboxylate contains phosphorus incorporations which are
present as a


-56-



mix of phosphono, end-type phosphino, and dialkylphosphino species or the
water soluble
salts thereof.
55. A composition as recited in claim 51 wherein said unsaturated monomers are
chosen
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

56. A composition as recited in claim 51 wherein acrylic acid is the sole
unsaturated
monomer.

57. A composition as recited in claim 51 wherein the sole unsaturated monomer
is selected
from the group consisting of maleic acid, itaconic acid, and maleic anhydride.
58. A composition as recited in claim 51 wherein one unsaturated monomer is
acrylic acid
and the other unsaturated monomer is selected from the group consisting of
maleic acid,
itaconic acid, and maleic anhydride.
59. A composition as recited in claim 52 wherein said unsaturated monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, S-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.
60. A composition as recited in claim 52 wherein acrylic acid is the sole
unsaturated
monomer.
61. A composition as recited in claim 52 wherein the sole unsaturated monomer
is selected
from the group consisting of maleic acid, itaconic acid, and maleic anhydride.

62. A composition as recited in claim 52 wherein one unsaturated monomer is
acrylic acid
and the other unsaturated monomer is selected from the group consisting of
maleic acid,
itaconic acid, and maleic anhydride.

-57-



63. A composition as recited in claim 53 wherein said unsaturated monomers are
seleted
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydxophthalic
anhydride.

64. A composition as recited in claim 53 wherein acrylic acid is the sole
unsaturated
monomer.

65. A composition as recited in claim 53 wherein the sole unsaturated monomer
is selected
from the group consisting of maleic acid, itaconic acid, and maleic anhydride.

66. A composition as recited in claim 53 wherein one unsaturated monomer is
acrylic acid
and the other unsaturated monomer is selected from the group consisting of
maleic acid,
itaconic acid, and maleic anhydride.

67. A composition as recited in claim 54 wherein said unsaturated monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-.tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

68. A composition as recited in claim 54 wherein acrylic acid is the sole
unsaturated
monomer.

69. A composition as recited in claim 54 wherein the sole unsaturated monomer
is selected
from the group consisting of maleic acid, itaconic acid, and maleic anhydride.

70. A composition as recited in claim 54 wherein one unsaturated monomer is
acrylic acid
and the other unsaturated monomer is selected from the group consisting of
maleic acid,
itaconic acid, and maleic anhydride.

71. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
a co-oligomer or copolymer obtained from the polymerization of two or more
unsaturated
monomers in the presence of a phosphorus containing compound, a major
proportion of

-58-


residues (more than 50% by weight) of the phosphorus-containing carboxylate
being derived
from carboxyl monomers which contain one or more carboxyl groups or which
contain one or
more groups that have been transformed after polymerization into carboxyl
groups, the
remaining residues being obtained from non-carboxyl monomers, and in which the
resulting
phosphorus-containing carboxylate contains phosphorus incorporations that are
predominantly
or exclusively present as end-type phosphino species or the water soluble
salts thereof.

72. A composition as recited in claim 71 wherein the non-carboxyl monomers are
selected
from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-hydroxy-3-
(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.

73. A composition as recited in claim 71 wherein said carboxyl monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic-acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

74. A composition as recited in claim 73 wherein the carboxyl monomer is
selected from
the group consisting of acrylic acid, maleic acid, itaconic acid, and maleic
anhydride.

75. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
a co-oligomer or copolymer obtained from the polymerization of two or more
unsaturated
monomers in the presence of a phosphorus containing compound, a major
proportion of
residues (more than 50% by weight) of the phosphorus-containing carboxylate
being derived
from carboxyl monomers which contain one or more carboxyl groups or which
contain one or
more groups that have been transformed after polymerization into carboxyl
groups, the
remaining residues being obtained from non-carboxyl monomers, and in which the
resulting
phosphorus-containing carboxylate contains phosphorus incorporations that are
predominantly
or exclusively present as phosphono species or the water soluble salts
thereof.


-59-


76. A composition as recited in claim 75 wherein the non-carboxyl monomers are
chosen
from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-hydroxy-3-
(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.

77. A composition as recited in claim 75 wherein said carboxyl monomers are
chosen from
the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid, itaconic
acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic acid,
mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

78. A composition as recited in claim 77 wherein the carboxyl monomer is
chosen from
the group consisting of acrylic acid, maleic acid, itaconic acid, and maleic
anhydride.

79. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
a co-oligomer, or copolymer obtained from the polymerization two or more
unsaturated
monomers in the presence of a phosphorus containing compound, a proportion of
residues of
more than 50% by weight of the entire compound, in the phosphorus-containing
carboxylate
being derived from monomers containing one or more carboxyl groups or
containing one or
more groups that have been transformed after polymerization into carboxyl
groups, the
remaining residues being obtained from monomers which do not contain either
carboxyl
groups or groups that have been transformed after polymerization into carboxyl
groups or non-
carboxyl monomers, and in which the resulting phosphorus-containing
carboxylate contains
phosphorus incorporations that are predominantly or exclusively present as
dialkylphosphino
species or the water soluble salts thereof.

80. A composition as recited in claim 79 wherein the non-carboxyl monomers are
selected
from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-hydroxy-3-
(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,


-60-


vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.

81. A composition as recited in claim 79 wherein said carboxyl monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

82. A composition as recited in claim 81 wherein the carboxyl monomer is
selected from
the group consisting of acrylic acid, maleic acid, itaconic acid, and maleic
anhydride. 83.
A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is a
co-oligomer or copolymer obtained from the polymerization of two or more
unsaturated
monomers in the presence of a phosphorus containing compound, a major
proportion of
residues (more than 50% by weight) of the phosphorus-containing carboxylate
being derived
from carboxyl monomers which contain one or more carboxyl groups or which
contain one or
more groups that have been transformed after polymerization into carboxyl
groups, the
remaining residues being obtained from non-carboxyl monomers, and in which the
resulting
phosphorus-containing carboxylate contains phosphorus incorporations that are
present as a
mixture of phosphono, end-type phosphino, and dialkylphosphino species or the
water soluble
salts thereof.

84. A composition as recited in claim 83 wherein the non-carboxyl monomers are
selected
from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-hydroxy-3-
(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
esters of acrylic or methacrylic acid, C1-C4 alkyl esters of acrylic or
methacrylic acid,
acrylamides, alkyl substituted acrylamides, allyl alcohol, 2-vinyl pyridine, 4-
vinyl pyridine,
N-vinylpyrrolidone, N-vinylformamide, N-vinylimidazole, vinyl acetate,
hydrolyzed vinyl
acetate, and styrene.


-61-


85. A composition as recited in claim 83 wherein said carboxyl monomers are
chosen from
the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid, itaconic
acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic acid,
mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

86. A composition as recited in claim 85 wherein the carboxyl monomer is
selected from
the group consisting of acrylic acid, maleic acid, itaconic acid, and maleic
anhydride.

87. A composition as recited in claim 2 wherein said phosphorus-containing
carboxylate is
a phosphonic polymer having the generalized formula

Image

wherein X j is H, an alkali metal atom, an alkaline earth metal atom, or an
ammonium or amine
residue; and R j1 is a copolymer residue comprising two different residues

Image

wherein z is an integer ranging from 2 to 100, and wherein, in the first
residue, R j2 is -COOH,
and in the second residue, R j2 is -CONHC(CH3)2CH2SO3X j wherein X j is as
hereinbefore
defined.

88. A composition as recited in claim 2 wherein the aqueous system treatment
material is a
composition of up to 50% by weight of a phosphonosuccinic acid, based on the
weight of the
composition, a phosphonated dimer of alkali metal maleate, not more than a
minor proportion
by weight, based on the weight of the dimer, of higher phosphonated oligomers
of maleate;
and from 0.5 to 5% by weight of the composition of an alkali metal phosphate.

89. A composition as recited in claim 2 wherein the long chain fatty acid
derivative
of a sarcosine is chosen to be N-Lauroylsarcosine or the water soluble salts
thereof.

90. A composition as recited in claim 1 wherein the composition includes
water.


-62-


91. A composition as recited in claim 2 wherein the composition additionally
includes
water.

92. A composition as recited in claim 2 wherein said composition additionally
contains at
least one additive chosen from the group consisting of:
i) one or more dispersants
ii) one or more copper corrosion inhibitors
iii) one or more aluminum corrosion inhibitors
iv) one or more water-soluble metal salts of metals chosen from the group
zinc,
manganese, aluminum, tin, nickel, yttrium, and the rare earth metals
v) one or more water-soluble organic metal chelates of metals ions chosen from
the group
zinc, manganese, aluminum, tin, nickel, yttrium, and the rare earth metals,
where the organic
chelant is chosen to impart a desired level of water solubility of the metal
ion
vi) one or more scale control agents
vii) one or more sequestering agents
viii) one or more anti-foaming agents
ix) one or more oxidizing biocides
x) one or more non-oxidizing biocides
xi) one or more water-soluble alcohols capable of lowering the freezing point
of an
aqueous system
xii) one or more ionic freezing point depressants
xiii) one or more p H adjusting agents
xiv) one or more inert tracers
xv) one or more active tracers
xvi) one or more water insoluble organic lubricants
xvii) one or more water soluble lubricants
xviii) one or more surfactants
xix) one or more calcium hardness adjusting agents, and
xx) one or more coloring agents

93. A composition as recited in claim 92 wherein the composition additionally
includes
water.

94. A composition as recited in claim 92 where the dispersant is a water-
soluble sulfonated
polymer or copolymer obtained from the polymerization of one or more
ethylenically
unsaturated monomers.


-63-


95. A composition as recited in claim 94 where the water-soluble sulfonated
copolymer is
about a 3:1 weight ratio copolymer of acrylic acid and allyl hydroxy propyl
sulfonate ether or
the water soluble salts thereof.
96. A composition as recited in claim 92 where the dispersant is a copolymer
of
diiosbutylene and malefic anhydride with molecular weight < 10,000 or its
water soluble salts.
97. A composition as recited in claim 92 where the copper corrosion inhibitor
is
tolyltriazole.
98. A composition as recited in claim 92 where the copper corrosion inhibitor
is a mixed
tolyltriazole composition including at least 65% of the 5-methylbenzotriazole
isomer by
weight.
99. A composition as recited in claim 92 where the copper corrosion inhibitor
is
benzotriazole.
100. A composition as recited in claim 92 where the copper corrosion inhibitor
is
mercaptobenzothiazole.
101. A composition as recited in claim 92 where the copper corrosion inhibitor
is an
akyl or alkoxy substituted benzotriazole wherein the substitution occurs on
the 4 or 5 position
of the benzene ring.
102. A composition as recited in claim 101 wherein the substituent is chosen
from
the group consisting of a n-butyl and hexyloxy.
103. A composition as recited in claim 92 where the copper corrosion inhibitor
is 1-
phenyl-5-mercaptotetrazole.
104. A composition as recited in claim 92 where the copper corrosion inhibitor
is a
halogen-tolerant azole.
105. A composition as recited in claim 104 where the halogen-tolerant azole is
chloro-tolyltriazole.
106. A composition as recited in claim 92 where the aluminum corrosion
inhibitor is
a water-soluble nitrate salt.
107. A composition as recited in claim 106 where the water-soluble nitrate
salt is
sodium nitrate.
108. A composition as recited in claim 92 where the water-soluble metal salt
is
obtained from zinc.
109. A composition as recited in claim 108 where the zinc salt is the sulfate,
chloride, acetate, or nitrate salt.
-64-


110. A composition as recited in claim 92 where the metal salt is obtained
from
manganese in the +2 oxidation state.
111. A composition as recited in claim 110 where the manganese salt state is
the
sulfate, chloride, acetate, or nitrate salt.
112. A composition as recited in claim 92 where the metal salt is obtained
from
lanthanum or a mixture of rare earth metals containing lanthanum.
113. A composition as recited in claim 112 where the lanthanum salt or mixture
of
rare earth metal salts containing lanthanum are independently selected from
the group
consisting of sulfate, chloride, acetate, and nitrate salts.
114. A composition as recited in claim 92 where the sequestering agent is
selected
from the group consisting of ethylenediaminetetra(acetic acid)
nitrolotriacetic acid, N,N-di(2-
hydroxyethyl)glycine and the water soluble salts thereof.
115. The composition as recited in claim 2 wherein the alkali metal silicate
is
sodium metasilicate.
116. A composition as recited in claim 92 where the anti-foaming agent is
selected
from the group consisting of silicones, polydimethylsiloxanes,
distearylsebacamide,
distearyladipamide, fatty alcehols; and ethylene oxide condensates of fatty
alcohols.
117. A composition as recited in claim 92 where the oxidizing biocide is
selected
from the group consisting of chorine, hypochlorite, bromine, hypobromite,
chlorine donor
compounds, bromine donor compounds, peracetic acid, inorganic peroxides and
peroxide
generators, chlorine dioxide, ozone and mixtures thereof.
118. A composition as recited in claim 92 where the non-oxidizing biocide is
selected from the group consisting of amines, quaternary ammonium compounds, 2-
bromo-2-
nitropropane-1,3-diol, .beta.-bromonitrostyrene, dodecylguanidine
hydrochloride, 2,2-dibromo-3-
nitrilopropionamide, gluteraldhyde, chlorophenols, sulphones, methylene bis
thiocyanates,
methylene bis carbamates, isothiazolones, brominated propionamides, triazines,
phosphonium
compounds, organometallic compounds and mixtures thereof.
119. A composition as recited in claim 92 where the non-oxidizing biocide is a
mixture of (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) a mixture of
about 75% 5-
chloro-2-methyl-4-isothiazolin-3-one and about 25% 2-methyl-4-isothiazolin-3-
one, the
weight ratio said BNPD (a) to said mixture (b) being about 16:1 to about 1:1.
-65-


120. A composition as recited in claim 92 where the water-soluble alcohol
freezing
point depressant is selected from the group consisting of ethylene glycol,
propylene glycol,
ethanol, glycerol, isopropanol, methanol and mixtures thereof.
121. A composition as recited in claim 92 where the ionic freezing point
depressant
is selected from the group consisting of calcium chloride, sodium chloride,
lithium bromide,
and lithium chloride.
122. A composition as recited in claim 92 where the pH adjusting agent is
selected
from the group consisting of sodium hydroxide, potassium hydroxide, lithium
hydroxide,
hydrochloric acid, sulfuric acid, nitric acid, carbon dioxide, ammonia,
organic acids such as
oxalic acid, alkali metal carbonates, and akali metal bicarbonates.
123. A composition as recited in claim 92 where the inert tracer is selected
from the
group consisting of soluble lithium salts, transition metals, and fluorescent
materials.
124. A composition as recited in claim 92 where the active tracer is selected
from
the group consisting of fluorescently tagged polymers, polymers containing a
photo-inert,
latently detectable moiety, water soluble molybdate salts, and azole-based
copper corrosion
inhibitors.
125. A composition as recited in claim 92 where the water insoluble organic
lubricant is selected from the group consisting of naturally occurring oils
and synthetic oils.
126. A composition as recited in claim 92 where the surfactant is selected
from the
group consisting of anionic, cationic, amphoteric, and nonionic surfactants.
127. A composition as recited in claim 92 where the calcium hardness adjusting
agent is selected from the group consisting of the bicarbonate, carbonate,
chloride, sulfate, and
acetate salts of calcium, calcium hydroxide and calcium oxide.
128. A composition as recited in claim 92 where the coloring agent is a water
soluble dye.
129. A composition as recited in claim 2 wherein said monofluorophosphate is
sodium monofluorophosphate.
130. A method for controlling the corrosion of metals in contact with an
aqueous
system having a pH of about 6 or greater which comprises introducing into said
system a
combination of:
(a) a tetrazolium compound of the formula:
-66-


Image
wherein R1, R2 and R3 are selected from the group consisting of lower alkyl,
branched lower
alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl and
heterocyclic substituted aryl,
with the proviso that neither R1, R2, or R3 contain more than 14 carbon atoms;
and n is 1 or 2,
such tetrazolium compound optionally having associated water soluble ionic
species if needed
to obtain a neutral charge, and
(b) at least one other aqueous system treatment material chosen so that the
material does
not substantially reduce the tetrazolium compound.
131. The method as recited in claim 130 wherein said other aqueous system
treatment material is selected from the group consisting of inorganic
phosphates, borates,
nitrites, compounds that release a metal anion in water, 2,3-dihydroxybenzoic
acid, 1,10-
phenanthroline, polycarboxylates, hydrocarbyl polycarboxylates, akyl
hydroxycarboxylic
acids, aminohydroxysuccinic acids, carboxyamines, polyepoxysuccinic acids,
modified
polyepoxysuccinic acids, monophosphonic acids, diphosphonic acids,
phosphonocarboxylic
acids, hydroxyphosphonocarboxylic acids, aminophosphonic acids,
phosphonomethylamine
oxides, polymeric amine oxides, polyetherpolyaminomethylene phosphonates,
polyetherpolyamino-methylene phosphonate N-oxides, iminoakylenephosphonic
acids, long
chain fatty acid derivatives of sarcosine; telomeric, co-telomeric, polymeric,
or copolymeric
phosphorus-containing carboxylates, alkali metal silicates,
monofluorophosphate, amines,
diamines, alkanolamines, ether amines, fatty amines and diamines, quaternized
amines,
oxyalkylated amines, akyl pyridines, tetrazoles, imidazoline and substituted
imidazolines,
amidoamines, polyamines, polyakylenepolyamines, alkyl derivatives of benzene
sulfonic acid,
benzoates and substituted benzoates, aminobenzoates, salicylates, dimer-trimer
acids,
petroleum oxidates, borogluconates; lignins, lignosulfonates, tannins;
straight chain C5-C11
-67-


monocarboxylates and C4-C15 .alpha.,.omega.-dicarboxylates; amine salts of
carboxylic acids and
mercaptocarboxylic acids, amino acids, polyamino acids, hydroxyether acids and
related
lactone compounds, N-acyliminodiacetic acids; triazine di- and tri-carboxylic
acis, phospho-
and phosphate esters; and monofluorophosphates; water soluble salts thereof,
and mixtures
thereof.
132. A method as recited in claim 130 wherein said tetrazolium compound is
selected from the group consisting of the water soluble salts of Nitro Blue
Tetrazolium (2,2'-
Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-dimethoxy-4,4'-biphenylene]
ditetrazolium),
Distyryl Nitroblue Tetrazolium (2,2'-Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-
dimethoxy-
4,4'-biphenylene] ditetrazolium), Tetranitro Blue Tetrazolium (3,3'-(3,3'-
Dimethoxy-4,4'-
biphenylene)-bis-[2,5-p-nitrophenyl-2H-tetrazolium) and Iodonitro Tetrazolium
(2-(4-
lodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium).
133. A method as recited in claim 131 wherein said tetrazolium compound is
selected from the group consisting of the water soluble salts of Nitro Blue
Tetrazolium (2,2'-
Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-dimethoxy-4,4'-biphenylene]
ditetrazolium),
Distyryl Nitroblue Tetrazolium (2,2'-Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-
dimethoxy-
4,4'-biphenylene] ditetrazolium);-Tetranitro Blue Tetrazolium (3,3'-(3,3'-
Dimethoxy-4,4'-
biphenylene)-bis-[2,5-p-nitrophenyl-2H-tetrazolium) and Iodonitro Tetrazolium
(2-(4-
lodophenyl)-3-(4-nitrophenyl)-S-phenyltetrazolium).
134. A method as recited in claim 130 wherein said water soluble ionic species
are
anions selected from the group consisting of halogens, nitrates, nitrites,
carbonates,
bicarbonates, sulfates, phosphates, and transition metal oxygenates.
135. A method as recited in claim 134 wherein said halogens are selected from
the
group consisting of chlorides, fluorides, bromides and iodides.
136. A method as recited in claim 135 wherein said halogen is chloride.
137. A method as recited in claim 134 wherein said transition metal oxygenate
is
selected from the group consisting of molybdate, chromate, and tungstate.
138. A method as recited in claim 137 wherein said transition metal oxygenate
is
molybdate.
139. A method as recited in claim 131 wherein said inorganic phosphates are
orthophosphates, polyphosphates, water soluble salts thereof and mixtures
thereof.
-68-


140. A method as recited in claim 131 wherein said inorganic phosphates are a
mixture of orthophosphoric acid and pyrophosphoric acid or the water-soluble
salts thereof.
141. A method as recited in claim 131 wherein said borate is a water-soluble
borate
selected from the group consisting of tetraborates, metaborates, and
orthoborates. 142. A
method as recited in claim 141 wherein said water-soluble borate is sodium
tetraborate or a
hydrate of sodium tetraborate.
143. A method as recited in claim 131 wherein said nitrite is sodium nitrite.
144. A method as recited in claim 131 wherein the metal anion releasing
compounds
are selected from the group consisting of the water soluble salts of
molybdate, tungstate,
vanadate, metavanadate, and chromate.
145. A method as recited in claim 144 wherein the water soluble salt of a
molybdate
is sodium molybdate or a hydrate of sodium molybdate.
146. A method as recited in claim 131 wherein said polycarboxylates comprise
aliphatic compounds containing between about 4 and about 20 carbon atoms which
are
multiply substituted with carboxylate groups or water soluble salts thereof.
147. A method as recited in claim 146 wherein said polycarboxylate is 1,2,3,4-
butanetctracarboxylic acid.
148. A method as recited in claim 131 wherein said polycarboxylate is a
homopolymer obtained from the polymerization of an ethylenically unsaturated
monomer
containing one or more carboxyl groups.
149. A method as recited in claim 148 wherein said homopolymer is polyacrylic
acid or its water soluble salts.
150. A method as recited in claim 148 wherein said homopolymer is polymaleic
acid or its water soluble salts.
151. A method as recited in claim 148 wherein said homopolymer is polymaleic
anhydride or its water soluble salts.
152. A method as recited in claim 131 wherein said polycarboxylate is a
copolymer
obtained from the polymerization of two or more different ethylenically
unsaturated
monomers, each of said monomers containing one or more carboxyl groups.
153. A method as recited in claim 131 wherein said alkyl hydroxycarboxylic
acid
has the generalized formula
HOOC -(R B1)a -(R B2)b -(R B2)c - R B4
-69-


where a, b, and c are integers from 0 to 6 and (a+b+c)>0 where R B1, R B2, RB3
comprise C=O or
CYZ, where Y and Z are separately selected from the group consisting of H, OH,
CHO,
COOH, CH3, CH2(OH), CH(OH)2, CH2(COOH), CH(OH)COOH, CH2(CHO) and
CH(OH)CHO, so selected that the molecule has a minimum of one OH group when
written in
its fully hydrated form and R B4 is either H or COOH, including the various
stereoisomers and
chemically equivalent cyclic, dehydrated, and hydrated forms of these acids
and hydrolyzable
esters and acetals that form the above compounds in water or the water soluble
salts of such
alkyl hydroxycarboxylic acids.
154. A method as recited in claim 153 wherein said akyl hydroxycarboxylic acid
is
chosen from the group consisting of tartaric acid, mesotartaric acid, citric
acid, gluconic acid,
glucoheptonic acid, ketomalonic acid, saccharic acid and the water soluble
salts thereof.
155. A method as recited in claim 131 wherein the said other aqueous system
treatment materials is a mixture of orthophosphoric acid or its water-soluble
salts and at least
one alkyl hydroxycarboxylic acid having the generalized formula:
HOOC -(R B1)a -(R B2)b -(R B3)c - R B4
where a, b, and c are integers from 0 to 6 and (a+b+c)>0 where R B1, R B2, R
B3 comprise C=O or
CYZ, where Y and Z are separately selected from the group of H, OH, CHO, COOH,
CH3,
CH2(OH), CH(OH)2, CH2(COOH), CH(OH)COOH, CH2(CHO) and CH(OH)CHO, so selected
that the molecule has a minimum of one OH group when written in its fully
hydrated form and
RB4 is either H or COOH, including the various stereoisomers and chemically
equivalent
cyclic, dehydrated, and hydrated forms of these acids and hydrolyzable esters
and acetals that
form the above compounds in water or the water soluble salts of such alkyl
hydroxycarboxylic
acids, and the water soluble salts thereof.
156. A method as recited in claim 155 wherein the hydroxycarboxylic acid is
selected from the group consisting of tartaric acid, mesotartaric acid, citric
acid, gluonic acid,
glucoheptonic acid, ketomalonic acid, saccharic acid and the water soluble
salts thereof.
157. A method as recited in claim 131 wherein said aminohydroxysuccinic acid
has
the generalized formula
-70-


Image
wherein R C1, is H or C1 to C4 alkyl, optionally substituted with -OH, -CO2H, -
SO3H, or phenyl,
C4 to C7 cycloalkyl, or phenyl which is optionally substituted with -OH or -
CO2H, and R C2 is
H, C1 to C6 alkyl, optionally substituted with -OH or -CO2H (specifically
including the moiety
-CH(CO2H)CH(OH)(CO2H)); and
Image
-71-


wherein R c2 is as above, and Z c is selected from the group consisting of
i)- (CH2)k wherein k is an integer from 2 to 10,
ii) -(CH2)2-X c-(CH2)2 wherein X c is -O-, -S-, -NR C3-, wherein RC3 is
selected from the
group consisting of H, C1 to C6 alkyl, hydroxyalkyl, carboxyalkyl, acyl, and -
C(O)ORC4
wherein R C4 is selected from the group consisting of C to C6 alkyl or benzyl
and a residue
having the general formula:
Image
wherein RC2 is as above,
iii) a residue having the generalized formula
Image
wherein Y is H, C1 to C6 alkyl, alkoxy, halogen, - CO2H, or - SO3H, m is
independently 0 or 1,
and p is 1 or 2, and
iv) a residue having the generalized formula:
Image
wherein R C5 and R C6 are independently H or C1 to C6 alkyl, Q is H or C1 to
C6 alkyl, s is 0, 1 or
2, t is independently 0, 1, 2, or 3, q is 0, 1, 2, or 3, and r is 1 or 2 or
water soluble salts thereof.
158. A method as recited in claim 157 wherein the aminohydroxysuccinic acid is
selected from the group consisting of iminodi(2-hydroxysuccinic acid), N, N'-
Bis(2-
-72-


hydroxysuccinyl)-1,6-hexanediamine, N,N'-Bis(2-hydroxysuccinyl)-m-
xylylenediamine, or
the water-soluble salts thereof.
159. A method as recited in claim 131 wherein said other aqueous system
treatment material is a mixture of orthophosphoric acid or its water-soluble
salts and at least
one aminohydroxysuccinic acid wherein said aminohydroxysuccinic acid has the
generalized
formula
Image
wherein RC1, is H or C1 to C4 alkyl, optionally substituted with optionally
substituted with -OH,
-CO2H, -SO3H, or phenyl, C4 to C7 cycloalkyl, or phenyl which is optionally
substituted with
-OH or -CO2H, and RC2 is H, C1 to C6 alkyl, optionally substituted with -OH or
CO2H
(specifically including the moiety -CH(CO2H)CH(OH)(CO2H)); and
Image
wherein RC2 is as above, and Z c is selected from the group consisting of
i)- (CH2)k wherein k is an integer from 2 to 10,
ii) -(CH2)2 X c-(CH2)2 wherein X c is -O-, -S-, or -NR C3, wherein RC3 is
selected from
the group consisting of H, C1 to C6 alkyl, hydroxyalkyl, carboxyalkyl, acyl, -
C(O)ORC4
wherein RC4 is selected from the group consisting of C1 to C6 alkyl or benzyl
and a residue
having the general formula:
-73-


Image
wherein R C2 is as above,
iii) a residue having the generalized formula
Image
wherein Y is H, C1 to C6 alkyl, alkoxy, halogen, -CO2H, or - SO3H, m is
independently 0 or 1,
and p is 1 or 2, and
iv) a residue having the generalized formula:
Image
wherein RC5 and RC6 are independently H or C1 to C6 alkyl, Q is H or C1 to C6
alkyl, s is 0, 1 or
2, t is independently 0, 1, 2, or 3, q is 0, 1, 2, or 3, and r is 1 or 2 or
water soluble salts thereof.
160. A method as recited in claim 159 wherein the aminohydroxysuccinic acid is
selected from the group consisting of iminodi(2-hydroxysuccinic acid), N, N'-
Bis(2-
hydroxysuccinyl)-1,6-hexanediamine, N,N'-Bis(2-hydroxysuccinyl)-m-
xylylenediamine, and
the water-soluble salts thereof.
161. A method as recited in claim 131 wherein the polyepoxysuccinic acid has
the generalized formula:
-74-


Image
where 1 ranges from about 2 to about 50, M T is hydrogen or a water soluble
cation and R T is
hydrogen, C1-4 alkyl or C1-4 substituted alkyl.
162. A method as recited in claim 161 wherein R T is hydrogen and 1 ranges
from
about 2 to about 10.
163. A method as recited in claim 161 wherein R T is hydrogen and 1 is from
about 4
to about 7.
164. A method as recited in claim 131 wherein the said other aqueous system
treatment material is a mixture of orthophosphoric acid or its water-soluble
salts and a
polyepoxysuccinic acid having the generalized formula:
Image
where 1 ranges from about 2 to about 50, M T is hydrogen or a water soluble
cation and R T is
hydrogen, C1-4 alkyl or C1-4 substituted alkyl, or the water soluble salts
thereof.
165. A method as recited in claim 164 wherein said polyepoxysuccinic acid has
R T
as hydrogen and 1 is from about 2 to about 10.
166. A method as recited in claim 164 wherein said polyepoxysuccinic acid has
R T
as hydrogen and 1 is from about 4 to about 7.
167. A method as recited in claim 131 wherein the modified polyepoxysuccinic
acid
has the generalized formula
-75-


Image
wherein R D1, when present, is H, a substituted or non-substituted alkyl or
aryl moiety having a
carbon chain up to the length where solubility in aqueous solution is lost, or
a repeat unit
obtained after polymerization of an ethylenically unsaturated compound; R D2
and R D3 each
independently are H, C1 to C4 alkyl or C1 to C4 substituted alkyl; Z D is O,
S, NH, or NR D1,
where R D1, is as described above, n is a positive integer greater than 1; f
is a positive integer;
and Mp is H, a water soluble cation, or a non-substituted lower alkyl group
having from 1 to 3
carbon atoms (when R D1, is not present, Z D may be M D O3S, where M D is as
described above).
168. A method as recited in claim 167 wherein R DI, is the meta-xylylene
moiety
(meta-CH2-C6H4 CH2-), R D2 and R D3 are both H, Z D is -NH, M D is Na or H,
and f=2, and a is a
positive integer greater thank.
169. The method as recited in claim 131 wherein said monophosphonic acid has
the
generalized formula:
Image
wherein R F is a C1 to C12 straight or branched chain alkyl residue, a C2 to
C12 straight or
branched chain alkenyl residue, a C5 to C12 cycloalkyl residue, a C6 to C10
aryl residue, or a C7
to C12 aralkyl residue, and where R F may additionally be singly or multiply
substituted with
groups independently chosen from hydroxyl, amino, or halogen, or the water
soluble salts
thereof.
170. A method as recited in claim 131 wherein said diphosphonic acid has the
generalized formula:
-76-


wherein R K is a C1 to C12 straight or branched chain alkylene residue, a C2
to C12 straight or
branched chain alkenylene residue, a C5 to C12 cycloalkylene residue, a C6 to
C10 arylene
residue, or a C7 to C12 aralkylene residue where R K may additionally be
singly or multiply
substituted with groups independently chosen from hydroxyl, amino, or halogen,
or the water
soluble salts thereof.
171. A method as recited in claim 170 wherein said diphosphonic acid is is 1-
hydroxyethane-1,1-diphosphonic acid or the water soluble salts thereof.
172. A method as recited in claim 131 wherein said phosphonocarboxylic acid
has
the generalized formulas
Image
where R H1, is H, an alkyl, alkenyl, or alkinyl radical having 1 to 4 carbon
atoms, an aryl,
cycloalkyl, or aralkyl radical, or the radical selected from the following:
Image
where R H2 is H, alkyl radical of 1 to 4 carbon atoms, or a carboxyl radical;
and X H is selected
from the following:
-77-


Image
and where the -PO3H2 group is the phosphono group
Image
or the water-soluble salts thereof.
173. A method as recited in claim 172 wherein said phosphonocarboxylic acid is
2-
phosphonobutane-1,2,4-tricarboxylic acid or the water soluble salts thereof.
174. A method as recited in claim 131 wherein said hydroxyphosphonocarboxylic
acid has the generalized formula
Image
wherein RE is H, a C1 to C12 straight or branched chain alkyl residue, a C2 to
C12 straight or
branched-chain alkenyl residue; a C5 to C12 cycloalkyl residue, a C6 to C10
aryl residue, or a C7
to C12 aralkyl residue, X E is an optional group, which when present is a C1
to C10 straight or
branched chain alkylene residue, a C2 to C10 straight or branched chain
alkenylene residue, or a
C6 to C10 arylene residue or water soluble salts thereof.
175. A method as recited in claim 174 wherein said hydroxyphosphonocarboxylic
acid is 2-hydroxy-phosphonoacetic acid or the water soluble salts thereof.
176. A method as recited in claim 131 wherein said aminophosphonic acid has
the
generalized formula:
-78-



Image

where R G2 is a lower alkylene having from about one to about four carbon
atoms, or an amine,
hydroxy, or halogen substituted lower alkylene; R G3 is R G2 ~ PO3H2, H, OH,
amino, substituted
amino, or R F, where R F is a C1 to C12 straight or branched chain alkyl
residue, a C2 to C12
straight or branched chain alkenyl residue, a C5 to C12 cycloalkyl residue, a
C6 to C10 aryl
residue, or a C7 to C12 aralkyl residue, and where R F may additionally be
singly or multiply
substituted with groups independently selected from the group consisting of
hydroxyl, amino,
and halogen, R G4 is R G3 or the group represented by the generalized formula:
Image
where R G5 and R G6 are each independently selected from the group consisting
of H, OH,
amino, substituted amino, and R F as previously defined; R G7 is R G5, R G6,
or the group R G2-
PO3H2 with R G2 as previously defined; v is an integer from 1 to about 15; and
w is an integer
from 1 through about 14 or water soluble salts thereof.

177. A method as recited in claim 176 wherein said aminophosphonic acid is
diethylenetriamine penta(methylenephosphonic acid) or the water soluble salts
thereof.

178. A method as recited in claim 131 wherein said phosphonomethyl amine oxide
has the generalized formula
Image

-79-



wherein either R A1 is selected from the group consisting of hydrocarbyl, and
hydroxy-
substituted, alkoxy-substituted, carboxyl-substituted and sulfonyl-substituted
hydrocarbyl; and
R A2 is selected from the group consisting of hydrocarbyl, and hydroxy-
substituted, alkoxy-
substituted, carboxyl-substituted and sulfonyl-substituted hydrocarbyl, -
CH2PO3H2, and
Image
or R A1 and R A2 together form an alicyclic ring having 3 to 5 carbon atoms in
the ring or a
water-soluble salt of said phosphonomethyl amine oxide. Hydrocarbyl includes
alkyl, aryl,
and alkaryl groups which do not render the amine oxide insoluble in water.

179. A method as recited in claim 178 wherein said phosphonomethyl amine oxide
is N,N-bis-phosphonomethylethanolamine N-oxide or the water soluble salts
thereof.

180. A method as recited in claim 131 wherein said phosphorus-containing
carboxylate is an oligomer, polymer, co-oligomer, or copolymer obtained from
the
polymerization of one or more unsaturated monomers in the presence of a
phosphorus
containing compound, said monomers containing one or more carboxyl groups or
containing
one or more groups that have been transformed after polymerization into
carboxyl groups, and
in which the resulting phosphorus containing carboxylate contains phosphorus
incorporations
that are predominantly or exclusively present as end-type phosphino species or
the water
soluble salts thereof.

181. A method as recited in claim 131 wherein said phosphorus-containing
carboxylate is an oligomer, polymer, co-oligomer, or copolymer obtained from
the
polymerization of one or more unsaturated monomers in the presence of a
phosphorus
containing compound, said monomers containing one or more carboxyl groups or
containing
one or more groups that have been transformed after polymerization into
carboxyl groups, and
in which the resulting phosphorus containing carboxylate contains phosphorus
incorporations
that are predominantly or exclusively present as phosphono species or the
water soluble salts
thereof.

182. A method as recited in claim 131 wherein said phosphorus-containing
carboxylate is an oligomer, polymer, co-oligomer, or copolymer obtained from
the

-80-




polymerization of one or more unsaturated monomers in the presence of a
phosphorus
containing compound, said monomers containing one or more carboxyl groups or
containing
one or more groups that have been transformed after polymerization into
carboxyl groups, and
in which the resulting phosphorus-containing carboxylate contains phosphorus
incorporations
that are predominantly or exclusively present as dialkylphosphino species or
the water soluble
salts thereof.

183. A method as recited in claim 131 wherein said phosphorus-containing
carboxylate is an oligomer, polymer, co-oligomer, or copolymer obtained from
the
polymerization of one or more unsaturated monomers in the presence of a
phosphorus
containing compound, said monomers containing one or more carboxyl groups or
containing
one or more groups that have been transformed after polymerization into
carboxyl groups and
in which the resulting phosphorus-containing carboxylate contains phosphorus
incorporations
which are present as a mix of phosphono, end-type phosphino, and
dialkylphosphino species
or the water soluble salts thereof.

184. A method as recited in claim 180 wherein said unsaturated monomers are
chosen from the group consisting of acrylic acid, maleic acid, maleic
anhydride, methacrylic
acid, itaconic acid, crotonicacid; vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic
acid, acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic
acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-
tetrahydrophthalic
anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-
2,3-dicarboxylic
anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic anhydride.

185. A method as recited in claim 180 wherein acrylic acid is the sole
unsaturated
monomer.

186. The method as recited in claim 180 wherein the sole unsaturated monomer
is
selected from the group consisting of maleic acid, itaconic acid, and maleic
anhydride.

187. A method as recited in claim 180 wherein one unsaturated monomer is
acrylic
acid and the other unsaturated monomer is selected from the group consisting
of maleic acid,
itaconic acid, and maleic anhydride.

188. A method as recited in claim 181 wherein said unsaturated monomers are
selected from the group consisting of acrylic acid, maleic acid, maleic
anhydride, methacrylic
acid, itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid,
citraconic acid, mesaconic
acid, acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic

-81-




acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-
tetrahydrophthalic
anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-
2,3-dicarboxylic
anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic anhydride.

189. A method as recited in claim 181 wherein acrylic acid is the sole
unsaturated
monomer.

190. A method as recited in claim 181 wherein the sole unsaturated monomer is
selected from the group consisting of maleic acid, itaconic acid, and maleic
anhydride.

191. A method as recited in claim 181 wherein one unsaturated monomer is
acrylic
acid and the other unsaturated monomer is selected from the group consisting
of maleic acid,
itaconic acid, and maleic anhydride.

192. A method as recited in claim 182 wherein said unsaturated monomers are
selected from the group consisting of acrylic acid, maleic acid, maleic
anhydride, methacrylic
acid, itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid,
citraconic acid, mesaconic
acid, acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic
acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-
tetrahydrophthalic
anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-
2,3-dicarboxylic
anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic anhydride.

193. A method as recited in claim 182 wherein acrylic acid is the sole
unsaturated
monomer.

194. A method as recited in claim 182 wherein the sole unsaturated monomer is
selected from the group consisting of maleic acid, itaconic acid, and maleic
anhydride.

195. A method as recited in claim 182 wherein one unsaturated monomer is
acrylic acid and
the other unsaturated monomer is selected from the group consisting of maleic
acid, itaconic
acid, and maleic anhydride.

196. A method as recited in claim 183 wherein said unsaturated monomers are
selected from the group consisting of acrylic acid, maleic acid, maleic
anhydride, methacrylic
acid, itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid,
citraconic acid, mesaconic
acid, acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic
acid, cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-
tetrahydrophthalic
anhydride, 5-norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-
2,3-dicarboxylic



-82-




anhydride, 3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic anhydride.

197. A method as recited in claim 183 wherein acrylic acid is the sole
unsaturated
monomer.

198. A method as recited in claim 183 wherein the sole unsaturated monomer is
selected from the group consisting of maleic acid, itaconic acid, and maleic
anhydride.

199. A method as recited in claim 183 wherein one unsaturated monomer is
acrylic
acid and the other unsaturated monomer is selected from the group consisting
of maleic acid,
itaconic acid, and maleic anhydride.

200. A composition as recited in claim 131 wherein said phosphorus-containing
carboxylate is a co-oligomer or copolymer obtained from the polymerization of
two or more
unsaturated monomers in the presence of a phosphorus containing compound, a
major
proportion of residues (more than 50% by weight) of the phosphorus-containing
carboxylate
being derived from carboxyl monomers which contain one or more carboxyl groups
or which
contain one or more groups that have been transformed after polymerization
into carboxyl
groups, the remaining residues being obtained from non-carboxyl monomers, and
in which the
resulting phosphorus-contain-ing carboxylate contains phosphorus
incorporations that are
predominantly or exclusively present as end-type phosphino species or the
water soluble salts
thereof.

201. A method as recited in claim 200 wherein the non-carboxyl monomers are
selected from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-
hydroxy-3-(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.

202. A method as recited in claim 200 wherein said carboxyl monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,



-83-




3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

203. A method as recited in claim 202 wherein the carboxyl monomer is selected
from the group consisting of acrylic acid, maleic acid, itaconic acid, and
maleic anhydride.

204. A composition as recited in claim 131 wherein said phosphorus-containing
carboxylate is a co-oligomer or copolymer obtained from the polymerization of
two or more
unsaturated monomers in the presence of a phosphorus containing compound, a
major
proportion of residues (more than 50% by weight) of the phosphorus-containing
carboxylate
being derived from carboxyl monomers which contain one or more carboxyl groups
or which
contain one or more groups that have been transformed after polymerization
into carboxyl
groups, the remaining residues being obtained from non-carboxyl monomers, and
in which the
resulting phosphorus-containing carboxylate contains phosphorus incorporations
that are
predominantly or exclusively present as phosphono species or the water soluble
salts thereof.

205. A method as recited in claim 204 wherein the non-carboxyl monomers are
chosen from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-
hydroxy-3-(2-
propenyloxyl propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.

206. A method as recited in claim 204 wherein said carboxyl monomers are
chosen
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

207. A method as recited in claim 206 wherein the carboxyl monomer is chosen
from the group consisting of acrylic acid, maleic acid, itaconic acid, and
maleic anhydride.

208. A composition as recited in claim 131 wherein said phosphorus-containing
carboxylate is a co-oligomer or copolymer obtained from the polymerization of
two or more



-84-




unsaturated monomers in the presence of a phosphorus containing compound, a
major
proportion of residues (more than 50% by weight) of the phosphorus-containing
carboxylate
being derived from carboxyl monomers which contain one or more carboxyl groups
or which
contain one or more groups that have been transformed after polymerization
into carboxyl
groups, the remaining residues being obtained from non-carboxyl monomers, and
in which the
resulting phosphorus-containing carboxylate contains phosphorus incorporations
that are
predominantly or exclusively present as dialkylphosphino species or the water
soluble salts
thereof.
209. A method as recited in claim 208 wherein the non-carboxyl monomers are
selected from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-
hydroxy-3-(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
and C1-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted
acrylamides, allyl alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-
vinylpyrrolidone, N-
vinylformamide, N-vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and
styrene.
210. A method as recited in claim 208 wherein said carboxyl monomers are
selected
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile, alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.
211. A method as recited in claim 210 wherein the carboxyl monomer is selected
from the group consisting of acrylic acid, maleic acid, itaconic acid, and
maleic anhydride.
212. A composition as recited in claim 131 wherein said phosphorus-containing
carboxylate is a co-oligomer or copolymer obtained from the polymerization of
two or more
unsaturated monomers in the presence of a phosphorus containing compound, a
major
proportion of residues (more than 50% by weight) of the phosphorus-containing
carboxylate
being derived from carboxyl monomers which contain one or more carboxyl groups
or which
contain one or more groups that have been transformed after polymerization
into carboxyl
groups, the remaining residues being obtained from non-carboxyl monomers, and
in which the
-85-




resulting phosphorus-containing carboxylate contains phosphorus incorporations
that are
present as a mixture of phosphono, end-type phosphino, and dialkylphosphino
species or the
water soluble salts thereof.
-86-




213. A method as recited in claim 212 wherein the non-carboxyl monomers are
selected from the group consisting of 2-acrylamido-2-methylpropanesulfonic, 2-
hydroxy-3-(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl
esters of acrylic or methacrylic acid, C1-C4 alkyl esters of acrylic or
methacrylic acid,
acrylamides, alkyl substituted acrylamides, allyl alcohol, 2-vinyl pyridine, 4-
vinyl pyridine,
N-vinylpyrrolidone, N-vinylformamide, N-vinylimidazole, vinyl acetate,
hydrolyzed vinyl
acetate, and styrene.

214. A method as recited in claim 212 wherein said carboxyl monomers are
chosen
from the group consisting of acrylic acid, maleic acid, maleic anhydride,
methacrylic acid,
itaconic acid, crotonic acid, vinyl acetic acid, fumaric acid, citraconic
acid, mesaconic acid,
acrylonitrile, methacrylonitrile,'alpha-methylene glutaric acid,
cyclohexenedicarboxylic acid,
cis-1,2,3,6-tetrahydrophthalic anhydride, 3,6-epoxy-1,2,3,6-tetrahydrophthalic
anhydride, 5-
norbornene-2,3-dicarboxylic anhydride, bicyclo[2.2.2]-5-octene-2,3-
dicarboxylic anhydride,
3-methyl-1,2,6-tetrahydrophthalic anhydride, and 2-methyl-1,3,6-
tetrahydrophthalic
anhydride.

215. A method as recited in claim 214 wherein the carboxyl monomer is selected
from the group consisting of acrylic acid, maleic acid, itaconic acid, and
maleic anhydride.

216. A method as recited in claim 131 wherein said phosphorus-containing
carboxylate is a phosphonic polymer having the generalized formula

Image

wherein X J is H, an alkali metal atom, an alkaline earth metal atom, or an
ammonium or amine
residue; and R J1 is a copolymer residue comprising two different residues

Image

wherein z is an integer ranging from 2 to 100, and wherein, in the first
residue, R J2 is -COOH,
and in the second residue, R J2 is -CONHC(CH3)2CH2SO3X J, wherein X J is as
hereinbefore
defined.



-87-




217. A method as recited in claim 131 wherein the aqueous system treatment
material is a composition of up to 50% by weight of a phosphonosuccinic acid,
based on the
weight of the composition, a phosphonated dimer of alkali metal maleate, not
more than a
minor proportion by weight, based on the weight of the dimer, of higher
phosphonated
oligomers of maleate; and from 0.5 to 5% by weight of the composition of an
alkali metal
phosphate.

218. A method as recited in claim 131 wherein the long chain fatty acid
derivative
of a sarcosine is chosen to be N-Lauroylsarcosine or the water soluble salts
thereof.

219. A method as recited in claim 130 wherein the composition includes water.

220. A method as recited in claim 131 wherein the composition additionally
includes water.

221. A method as recited in claim 131 wherein said composition additionally
contains at least one additive chosen from the group consisting of:
i. one or more dispersants
ii. one or more copper corrosion inhibitors
iii. one or more aluminum corrosion inhibitors
iv. one or more water-soluble metal salts of metals chosen from the group
zinc,
manganese, aluminum, tin, nickel, yttrium, and the rare earth metals
v. one or more water-soluble organic metal chelates of metals ions chosen from
the group zinc, manganese, aluminum, tin, nickel, yttrium, and the rare earth
metals, where the organic chelant is chosen to impart a desired level of water
solubility of the metal ion
vi. one or more scale control agents
vii. one or more sequestering agents
viii. one or more anti-foaming agents
ix. one or more oxidizing biocides
x. one or more non-oxidizing biocides
xi. one or more water-soluble alcohols capable of lowering the freezing point
of an
aqueous system
xii. one or more ionic freezing point depressants
xiii. one or more pH adjusting agents
xiv. one or more inert tracers
xv. one or more active tracers



-88-




xvi. one or more water insoluble organic lubricants
xvii. one or more water soluble lubricants
xviii. one or more surfactants
xix. one or more calcium hardness adjusting agents, and
xx. one or more coloring agents.

222. A method as recited in claim 221 wherein the composition additionally
includes water.

223. A method as recited in claim 221 where the dispersant is a water-soluble
sulfonated polymer or copolymer obtained from the polymerization of one or
more
ethylenically unsaturated monomers.

224. A method as recited in claim 223 where the water-soluble sulfonated
copolymer is about a 3:1 weight ratio copolymer of acrylic acid and allyl
hydroxy propyl
sulfonate ether or the water soluble salts thereof.

225. A method as recited in claim 221 where the dispersant is a copolymer of
diiosbutylene and maleic anhydride with molecular weight<10,000 or its water
soluble salts.

226. A method as recited in claim 221 where the copper corrosion inhibitor is
tolyltriazole.

227. A method as recited in claim 221 where the copper corrosion inhibitor is
a
mixed maleic composition including at least 65% of the 5-methylbenzotriazole
isomer
by weight.

228. A method as recited in claim 221 where the copper corrosion inhibitor is
benzotriazole.

229. A method as recited in claim 221 where the copper corrosion inhibitor is
mercaptobenzothiazole.

230. A method as recited in claim 221 where the copper corrosion inhibitor is
an
akyl or alkoxy substituted benzotriazole wherein the substitution occurs on
the 4 or 5
position of the benzene ring.

231. A method as recited in claim 230 wherein the substituent is chosen from
the
group consisting of n-butyl and hexyloxy.

232. A method as recited in claim 221 where the copper corrosion inhibitor is
1-
phenyl-5-mercaptotetrazole.

233. A method as recited in claim 221 where the copper corrosion inhibitor is
a
halogen-tolerant azole.



-89-




234. A method as recited in claim 233 where the halogen-tolerant azole is
chloro-
tolyltriazole.

235. A method as recited in claim 221 where the aluminum corrosion inhibitor
is a
water-soluble nitrate salt.

236. A method as recited in claim 235 where the water-soluble nitrate salt is
sodium
nitrate.

237. A method as recited in claim 221 where the water-soluble metal salt is
obtained
from zinc.

238. A method as recited in claim 237 where the zinc salt is the sulfate,
chloride,
acetate, or nitrate salt.

239. A method as recited in claim 221 where the metal salt is obtained from
manganese in the +2 oxidation state.

240. A method as recited in claim 239 where the manganese salt state is the
sulfate,
chloride, acetate, or nitrate salt.

241. A method as recited in claim 221 where the metal salt is obtained from
lanthanum or a mixture of rare earth metals containing lanthanum.

242. A method as recited in claim 241 where the lanthanum salt or mixture of
rare
earth metal salts containing lanthanum are independently selected from the
group consisting of
the sulfate, chloride, acetate, and nitrate salts.

243. A method as recited in claim 221 where the sequestering agent is selected
from
the group consisting of ethylenediaminetetra(acetic acid), nitrolotriacetic
acid, N,N-di(2-
hydroxyethyl)glycine and the water soluble salts thereof.

244. A method as recited in claim 131 wherein the alkali metal silicate is
sodium
metasilicate.

245. A method as recited in claim 221 where the anti-foaming agent is selected
from
the group consisting of silicones, polydimethylsiloxanes,
distearylsebacamides,
distearyladipamide, fatty alcohols, and ethylene oxide condensates of fatty
alcohols.

246. A method as recited in claim 221 where the oxidizing biocide is selected
from
the group consisting of chorine, hypochlorite, bromine, hypobromite, chlorine
donor
compounds, bromine donor compounds, peracetic acid, inorganic peroxides and
peroxide
generators, chlorine dioxide, ozone and mixtures thereof.

247. A method as recited in claim 221 where the non-oxidizing biocide is
selected
from the group consisting of amines, quaternary ammonium compounds, 2-bromo-2-



-90-




nitropropane-1,3-diol, .beta.-bromonitrostyrene, dodecylguamctme hydrochlonde,
2,2-dibromo-3-
nitrilopropionamide, gluteraldhyde, chlorophenols, sulphones, methylene bis
thiocyanates,
methylene bis carbamates, isothiazolones, brominated propionamides, triazines,
phosphonium
compounds, organometallic compounds and mixtures thereof.

248. A method as recited in claim 221 where the non-oxidizing biocide is a
mixture
of (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) a mixture of about 75% 5-
chloro-2-
methyl-4-isothiazolin-3-one and about 25% 2-methyl-4-isothiazolin-3-one, the
weight ratio
said BNPD (a) to said mixture (b) being about 16:1 to about 1:1.

249. A method as recited in claim 221 where the water-soluble alcohol freezing
point depressant is selected from the group consisting of ethylene glycol,
propylene glycol,
ethanol, glycerol, isopropanol, and methanol, or mixtures thereof.

250. A method as recited in claim 221 where the ionic freezing point
depressant is
selected from the group consisting of calcium chloride, sodium chloride,
lithium bromide, and
lithium chloride.

251. A method as recited in claim 221 where the pH adjusting agent is selected
from
the group consisting of sodium hydroxide, potassium hydroxide, lithium
hydroxide,
hydrochloric acid, sulfuric acid, nitric-acid, carbon dioxide, ammonia,
organic acids such as
oxalic acid, alkali metal carbonates, and alkali metal bicarbonates.

252. A method as recited in claim 221 where the inert tracer is selected from
the
group consisting of soluble lithium salts, transition metals, and fluorescent
materials.

253. A method as recited in claim 221 where the active tracer is selected from
the
group consisting of fluorescently tagged polymers, polymers containing a photo-
inert, latently
detectable moiety, water soluble molybdate salts, and azole-based copper
corrosion inhibitors.

254. A method as recited in claim 221 where the water insoluble organic
lubricant is
selected from the group consisting of naturally occuring oils and synthetic
oils.

255. A method as recited in claim 221 where the surfactant is selected from
the
group consisting of anionic, cationic, amphoteric, and nonionic surfactants.

256. A method as recited in claim 221 where the calcium hardness adjusting
agent is
selected from the group consisting of the bicarbonate, carbonate, chloride,
sulfate, and acetate
salts of calcium, calcium hydroxide and calcium oxide.

257. A method as recited in claim 221 where the coloring agent is a water
soluble
dye.



-91-



258. A method as recited in claim 131 wherein said monofluorophosphate is
sodium
monofluorophosphate.
259. A method as recited in claim 155 wherein the weight ratio of ortho-
phosphate
species to pyrophosphate species is in the range of about 20:1 to about 1:20,
when both
species are expressed as PO4 -3.
260. A method according to claim 130 where the aqueous system is a cooling
water
system.
261. A method according to claim 260 where the cooling system is an open,
evaporative cooling water system.
262. A method according to claim 260 where the cooling system is a once-
through
system.
263. A method according to claim 260 where the cooling system is closed loop
cooling system.
264. A method according to claim 263 where the closed loop cooling system is
the
cooling system of an internal combustion engine.
265. A method according to claim 263 where the closed loop cooling system is a
brine-based system which captains at least one additive selected from the
group consisting of
calcium chloride, lithium chloride, lithium bromide, and sodium chloride.
266. A method according to claim 263 where the closed loop cooling system is a
system which contains at least one additive chosen from the group consisting
of ethylene
glycol, propylene glycol, ethanol, glycerol, isopropanol, and methanol.
267. A method according to claim 130 where the aqueous system is a hot water
heating system.
268. A method according to claim 130 where the aqueous system is selected from
the group consisting of pulping and papermaking systems, food and beverage
systems, boiler
systems, refinery systems, petrochemical processing systems, mining systems,
and metal
machining systems which utilize aqueous metal working fluids.
270. A method according to claim 130 where the aqueous system contains a fluid
that is at least 5 percent by weight water.
271. A method according to claim 130 where the aqueous system contains a fluid
that is at least 50 percent by weight water.
272. A method according to claim 130 where the aqueous system contains a fluid
that is at least 90 percent by weight water.

-92-



273. A method according to claim 130 where the aqueous system contains
dissolved
oxygen.
274. A method according to claim 130 where the aqueous system is substantially
or
completely free of dissolved oxygen.
275. A method according to claim 130 where the aqueous system contains at
least
one dissolved gas chosen from group consisting of oxygen, carbon dioxide,
hydrogen sulfide,
and ammonia.
276. A method according to claim 130 where the aqueous system contains ferrous
metal.
277. A method according to claim 276 where the ferrous metal is at least one
metal
selected from the group of cast iron, mild steel, low alloy steel, and
stainless steel.
278. A method according to claim 130 where the aqueous system contains non-
ferrous metal.
279. A method according to claim 278 where the non-ferrous metal is at least
one
metal selected from the group consisting of aluminum, copper, and the copper-
based alloys.
280. A method according to claim 130 where the aqueous system contains both
ferrous and non-ferrous metals.
281. A method according to claim 130 where the components are introduced into
the
system at an effective concentration by a slug feed.
282. A method according to claim 130 where the components are fed into the
system
using a combination of intermittent and continuous methods.
283. A method according to claim 130 where some of the components are fed into
the system on a continuous basis and the remaining components are fed on an
intermittent
basis.
284. A method according to claim 130 where components are introduced into the
aqueous system at an effective concentration by a controlled release delivery
system.
285. A method according to claim 130 where the combination of components is
introduced into said aqueous system at a total concentration of about 0.5 to
about 10,000 parts
per million by weight.
286. A method according to claim 130 where the combination of components is
introduced into said aqueous system at a total concentration of about 10 to
about 1,000 parts
per million by weight.

-93-



287. A method according to claim 130 where the weight ratio of component b) to
component a) is from about 100:1 to about 1:20.
288. A method according to claim 130 where the weight ratio of component b) to
component a) is from about 20:1 to about 1:1.
289. A method according to claim 130 where the pH of said aqueous system is
from
about 6 to about 10.
290. A method of controlling corrosion, deposition, and scale in an aqueous
system
having a pH of about 6 or greater which comprises introducing into said system
a combination
of:
(a) a tetrazolium compound of the formula:

Image

wherein R1, R2 and R3 are selected from the group consisting of lower alkyl,
branched lower
alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl and
heterocyclic substituted aryl,
with the proviso that neither R1, R2, or R3 contain more than 14 carbon atoms;
and n is 1 or 2,
such tetrazolium compound optionally having associated water soluble ionic
species if needed
to obtain a neutral charge, and
(b) at least one other aqueous system treatment material chosen so that the
material
does not substantially reduce the tetrazolium compound, and additionally
selected so that at
least one of these treatments is effective in inhibiting scale and/or
deposition.
291. A method for controlling corrosion of stainless steel in contact with an
aqueous
system which comprises introducing into said system at least one tetrazolium
compound of the
formula:

-94-




Image

wherein R1, R2 and R3 are selected from the group consisting of lower alkyl,
branched lower
alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl and
heterocyclic substituted aryl,
with the proviso that neither R1, R2, or R3 contain more than 14 carbon atoms;
and n is 1 or 2,
such tetrazolium compound optionally having associated water soluble ionic
species if needed
to obtain a neutral charge.
292. The method as recited in claim 300, wherein the aqueous system includes
at least
one other aqueous system treatment material chosen so that the material does
not substantially
reduce the tetrazolium compound.
293. The method as recited in claim 130 or 291 wherein the aqueous system
contains
dissolved oxygen.
294. The method as recited in claim 130 or 291 wherein the at least one
tetrazolium is
added to the aqueous system at active treatment levels ranging from about 0.1
to about 50
parts per million.
295. The method as recited in claim 294 wherein the at least one tetrazolium
compound is added to the aqueous system at active treatment levels ranging
from about 1 to
about 25 parts per million.
296. The method as recited in claim 130 or 291 wherein the at least one
tetrazolium
compound is added to the aqueous system at active treatment levels ranging
from about 0.1 to
about 50 parts per million and the aqueous system contains oxygen.
297. The method as recited in claim 296 wherein the at least one tetrazolium
compound is added to the aqueous system at active treatment levels ranging
from about 1 to
about 25 parts per million.

-95-

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
METHOD AND COMPOSITION FOR INHIBITING
CORROSION IN AQUEOUS SYSTEMS
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a Continuation-In-Part of Application No. 09/136,884,
filed August 19,
1998, a Continuation-In-Part of Applicatmi~ No: (?9/303,596, filed May 3,
1999, and a
Continuation-In-Part of Application No. 09/304,181, filed May 3, 1999. The
disclosures of each
of these applications is incorporated by reference in its entirety.
Metals are widely used in the construction of equipment associated with
aqueous systems.
By "aqueous systems" it is meant any system containing metals which contain or
are contacted
with aqueous fluids on a regular basis. Water-based fluids are typically
fluids that contain at least
about 50 weight percent water, the remainder being solids (suspended and/or
dissolved) and/or
nonaqueous fluids. The term aqueous fluids is intended to include not only
water-based fluids,
but also fluids that are predominantly non-aqueous but have sufficient water
present, at least about
5 weight percent water, so that water soluble treatment components may be
effectively employed
to limit corrosion. Such non-aqueous fluids may be miscible or immiscible with
water.
Typical aqueous systems include, but are not limited to, open recirculating
cooling systems
which obtain their source of cooling by evaporation, closed loop cooling
systems, boilers and
similar steam generating systems, heat exchange equipment, reverse osmosis
equipment, oil
production systems, flash evaporators, desalinization plants, gas scrubbers,
blast furnaces, paper
and pulp processing equipment, steam power plants, geothermal systems, food
and beverage
processing equipment, sugar evaporators, mining circuits, bottle washing
equipment, soil
irrigation systems, closed circuit heating systems for residential and
commercial use, aqueous-
based refrigeration systems, down-well systems, aqueous machining fluids (e.g.
for use in boring,
milling, reaming, broaching, drawing, turning, cutting, sewing, grinding and
in thread-cutting
operations, or in non-cutting shaping, spinning, drawing, or rolling
operations), aqueous scouring
systems, aqueous glycol anti-freeze systems, water/glycol hydraulic fluids,
ferrous surface pre-
treatment, polymer coating systems, and the like. Various types of water may
be utilized in such
systems, for example fresh water, brackish water, sea water, brines, sewage
effluents, industrial
waste waters, and the like.
The aqueous systems that may be treated using the compositions of this
invention may
contain dissolved oxygen, such as might be obtained from absorbing oxygen from
ambient air, or
-1-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
they may be substantially or completely oxygen free. Further, the aqueous
system may contain
other dissolved gases such as carbon dioxide, hydrogen sulfide, or ammonia, or
they maybe
substantially or completely free of such gases.
There may be several different types of corrosion encountered in aqueous
systems. For
example, aqueous systems may have uniform corrosion over the entire metal
surface. The
aqueous system may also have localized corrosion, such as pitting or crevice
corrosion, where the
corrosion is found only in certain locations on the metal surface. Often,
control of localized
corrosion may be the critical factor in prolonging the useful life of the
metal equipment in the
aqueous system. In particular, aqueous systems which contain high levels of
aggressive anions
such as chloride and sulfate are particularly prone to both generalized and
localized attack. These
aggressive anions may be present in the water source used for the aqueous
system at levels that
cause problems, or they may be concentrated to harmful levels in the aqueous
system because they
are part of a system that evaporates water such as an evaporative cooling
system.
Localized corrosion may pose even a greater threat to the normal operation of
the system
than general corrosion because such corrosion will occur intensely in one
location and may cause
perforations in the system structure carrying the fluid stream. Obviously,
these perforations may
cause leaks which require shutdown of the entire aqueous system so that repair
can be made.
Indeed, corrosion problems usually result in immense maintenance costs, as
well as costs incurred
as a result of equipment failure. Therefore, the inhibition of metal corrosion
in aqueous systems
is critical.
In the descriptions that follow, we utilize the terms oligomer, polymer, co-
oligomer, and
co-polymer. By oligomer we mean materials produced by the polymerization of a
single monomer
where the number of monomer units incorporated in the product is between 2 and
about 10. By
polymer, we mean materials produced by the polymerization of a single monomer
without
restriction on the number of monomer units incorporated into the product. By
co-oligomer, we
mean materials produced by the polymerization of more than one type of monomer
(including 2,
3, 4, etc. different monomers) where the total number of monomer units
incorporated in the
product is between 2 and about 10. By co-polymers, we mean materials produced
by the
polymerization of more than one type of monomer (including 2, 3, 4, etc.
different monomers)
without restriction on the number of monomer units incorporated into the
product.
In aqueous systems, the following corrosion reactions of metals, such as
steel, occur:
-2-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Fe O FezT + 2e
Fe (0H)2 + OH- O Fe (0H)3 + a
When tetrazolium compounds possessing redox potentials higher than that of the
corroding
metals or alloys are employed, reduction of tetrazolium molecules readily
occurs on the metal,
e.g., steel or stainless steel surface to form insoluble materials and, hence,
prevent steel from
further corrosion.
The method of the present invention comprises treating industrial waters with
a tetrazolium
salt of the general formula:
to
N N+
N
~ N
R3 R2 n
wherein R,, Rz and R3 can be various organic and inorganic substituents, e.g.,
from the
group consisting of lower alkyl, aryl, aralkyl, and heterocyclic substituted
aryl with the proviso
that neither R,, RZ or R3 contain more than 14 carbon atoms, and n may be 1 or
2.
The compounds may contain positive or negative counter ions in order to
balance the
charges on the above structure. Chemical or electrochemical reduction of this
type of compound
produces tetrazolinyls and fortnazans that readily adsorb on metal surfaces
and provide films for
corrosion protection.
We have also discovered that certain tetrazolium compounds given by the
generalized
formula:
-3-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
R1
N N+
s N
~N
R3 R2 n
wherein R~, RZ and R3 can be various organic and inorganic substituents, e.g.,
from the group
consisting of lower alkyl, branched lower alkyl, aryl, substituted aryl,
alkylaryl, substituted
alkylaryl and heterocyclic substituted aryl with the proviso that none of Rl,
RZ or R3 contain more
than 14 carbon atoms, and n may be 1 or 2, synergistically combine with a wide
range of
compounds to provide effective general and localized corrosion protection for
metals in aqueous
systems. If the components chosen to be combined with the tetrazolium
compounds are also scale
1 s and/or deposition inhibitors, the combinations will also provide scale
and/or deposition inhibition
for these aqueous systems.
Anions and/or canons may be associated with the above structure to balance the
charge
depending upon the substitutions employed. If R,, R, and R3 are all neutral,
then the structure
shown in the above formula will be positively charged and anionic species will
be needed.
The anions and/or cations utilized for balancing can be any such anions and/or
canons,
such as halogens, nitrates, nitrites, carbonates, bicarbonates, sulfates,
phosphates, and transition
metal oxygenates.
Anions and/or cations may be associated with the above structure to balance
the charge
depending upon the substitutions employed. If R~, R, and R3 are all neutral,
then the structure
2s shown in the above formula will be positively charged and anionic species
will be needed. For
example, the tetrazolium compounds according to the present invention are
neutral. In the
simplest case, if all of R,, Rz and R3 are neutral, then a counter ion that is
an anion with a single
negative charge, e.g., Cl-, will be needed to balance change for n=1. For n=2,
then two anions,
each with a single negative charge or one anion with a double negative charge,
e.g., S04 2, would
be needed to balance the charge. Moreover, for example, the charge associated
with R,, Rz and
R3 is not neutral, such as if the groups included sulfono, carboxyl and/or
quaternary nitrogen,
associated counter-ions should be present to provide a neutral charge for the
tetrazolium
-4-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
compound. Thus, for example, if n=2, and R, is substituted with a single
carboxyl group (COO-),
then the tetrazolium compound could be a zinc chloride salt wherein the Znl2
neutralizes the two
carboxyl charges and the CI- neutralizes the positive charge of the two ring
nitrogens.
Examples of such tetrazolium compounds that may be utilized according the this
invention
include Nitroblue Tetrazolium chloride (3,3'-(3,3'-Dimethoxy-4,4'-biphenylene)-
bis-[2-p-
nitrophenyl-5-phenyl-2H-tetrazolium chloride]), hereafter referred to as NBT,
Distyryl Nitroblue
Tetrazolium Chloride (2,2'-Di-p-nitrophenyl-5,5'-distyryl-3,3'-[3,3'-dimethoxy-
4,4'-
biphenylene] ditetrazolium chloride), hereafter referred to as DNBT,
Tetranitroblue Tetrazolium
chloride (3,3'-(3,3'-Dimethoxy-4,4'-biphenylene)-bis-[2,5-p-nitrophenyl-2H-
tetrazolium
chloride]), hereafter referred to as TNBT, and Iodonitro tetrazolium chloride
(2-(4-Iodophenyl)-3-
(4-nitrophenyl)-5-phenyltetrazolium chloride) hereafter referred to as INT.
The metals in the aqueous system can be any metal for which corrosion and/or
scaling can
be prevented. For example, the metal can be non-ferrous metals, such as
copper, aluminum, or
ferrous metals, such as iron, steel, e.g. low carbon steel, and stainless
steel, e.g. iron based alloys
containing chromium as the main alloying element, such as steels containing
between about 11
to 30% Cr, which exhibit excellent corrosion resistance to many environments.
The present invention provides particularly beneficial results in that even
when the
tetrazolium compound is utilized by itself without the addition of other
materials, including other
anti-corrosion and/or scale prevention ingredients, low concentrations of the
tetrazolium
compounds can be utilized. This is especially the situation when the
tetrazolium compounds are
utilized in aqueous systems, in the presence of oxygen, wherein the pH of the
system to be treated
is about 6 or greater, such as cooling water systems, steam generating
systems, gas scrubbing
systems, and pulping and papermaking systems.
The tetrazolium compounds of the present invention can preferably be added to
the
aqueous system at active treatment levels ranging from about 0.1 to about SO
parts per million,
with treatment levels of from about 1 to about 25 parts per million being
particularly preferred.
In one preferred aspect, the present invention is directed to methods for
controlling
corrosion of stainless steel in contact with an aqueous system which comprises
introducing into
said system at least one tetrazolium compound of the formula:
-5-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Ri
N N+
s N
'N
R3 R2 n
wherein R~, RZ and R3 are selected from the group consisting of lower alkyl,
branched lower alkyl,
aryl, substituted aryl, alkylaryl, substituted alkylaryl and heterocyclic
substituted aryl, with the
proviso that neither R,, Rz, or R3 contain more than 14 carbon atoms; and n is
1 or 2, such
tetrazolium compound optionally having associated water soluble ionic species
if needed to obtain
a neutral charge.
The aqueous system can include at least one other aqueous system treatment
material
chosen so that the material does not substantially reduce the tetrazolium
compound. Such material
can be added with the tetrazolium compound or separately therefrom.
The other aqueous system treatment material is selected from the group
consisting of
inorganic phosphates, borates, nitrites, compounds that release a metal anion
in water, 2,3-
dihydroxybenzoic acid, 1,10-phenanthroline, polycarboxylates, hydrocarbyl
polycarboxylates,
alkyl hydroxycarboxylic acids, aminohydroxysuccinic acids, carboxyamines,
polyepoxysuccinic
acids, modified polyepoxysuccinic acids, monophosphonic acids, diphosphonic
acids,
phosphonocarboxylic acids, hydroxyphosphonocarboxylic acids, aminophosphonic
acids,
phosphonomethylamine oxides, polymeric amine oxides,
polyetherpolyaminomethylene
2s phosphonates, polyetherpolyamino-methylene phosphonate N-oxides,
iminoalkylenephosphonic
acids, long chain fatty acid derivatives of sarcosine; telomeric, co-
telomeric, polymeric, or
copolymeric phosphorus-containing carboxylates, alkali metal silicates,
monofluorophosphate,
amines, diamines, alkanolamines, ether amines, fatty amines and diamines,
quaternized amines,
oxyalkylated amines, alkyl pyridines, tetrazoles, imidazoline and substituted
imidazolines,
amidoamines, polyamines, polyalkylenepolyamines, alkyl derivatives of benzene
sulfonic acid,
benzoates and substituted benzoates, aminobenzoates, salicylates, dimer-trimer
acids, petroleum
oxidates, borogluconates; lignins, lignosulfonates, tannins; straight chain CS-
C" monocarboxylates
-6-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
and C4-C15 a,w-dicarboxylates; amine salts of carboxylic acids and
mercaptocarboxylic acids,
amino acids, polyamino acids, hydroxyether acids and related lactone
compounds, N-
acyliminodiacetic acids; triazine di- and tri-carboxylic acids, phospho- and
phosphate esters; and
monofluorophosphates; water soluble salts thereof, and mixtures thereof.
Moreover, as noted above, the present invention also provides beneficial
results when
combined with other compounds, such as compounds disclosed in U.S. Patent
Application Nos.
09/136,884, filed August 19, 1998, 09/303,596, filed May 3, 1999, 09/304,181,
filed May 3, 1999,
and 09/309,564, filed May 12, 1999, the disclosures of which are incorporated
by reference herein.
Examples of compounds that may be combined with the tetrazolium compounds to
provide
synergistically improved corrosion protection include: inorganic phosphates,
such as
orthophosphates or polyphosphates, borates, nitrites, and compounds that
release a metal anion
in water, where the metal anion is selected from the group consisting of
molybdates, tungstates,
vanadates, metavanadates, chromates or mixtures thereof.
The inorganic phosphates can include orthophosphates, polyphosphates, water
soluble salts
thereof and mixtures thereof, such as a mixture of orthophosphoric acid and
pyrophosphoric acid
or the water-soluble salts thereof, such as the sodium and potassium salts
thereof.
The borates can comprise various borates, such as water-soluble borate
selected from
tetraborates, metaborates, and/or orthoborates, such as sodium tetraborate or
a hydrate of sodium
tetraborate.
The nitrates can include nitrites such as sodium nitrite.
Additional materials that may be combined with the tetrazolium compounds
include
polyacrylic acid or polymaleic acid, such as disclosed in the above-noted U.S.
Application No.
09/304,181, filed May 3, 1999. Particularly preferred polyacrylic and
polymaleic acids have a
molecular weight of about 8,000 or below.
Additional materials that may be combined with the tetrazolium compounds
include
polycarboxylates. The polycarboxylates may be simple aliphatic compounds
containing between
4 and about 20 carbon atoms in the aliphatic chain which are multiply
substituted with carboxyl
groups (e.g., Cg-C,5 a,w-dicarboxylates or compounds such as l, 2, 3, 4-
butanetetracarboxylic
acid) or water soluble salts thereof, or may be polymeric compounds. The
polymeric
polycarboxylates may be homopolymers or copolymers (including terpolymers,
tetrapolymers,
etc.) of ethylenically unsaturated monomers that contain a carboxyl group. The
polycarboxylates
can comprise a copolymer obtained from the polymerization of two or more
different ethylenically
-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
unsaturated monomers, each of the monomers containing one or more carboxyl
groups.
Examples of such polymeric polycarboxylates include polyacrylic acid,
polymaleic acid, and
polymaleic anhydride, and their water soluble salts. Additionally, the
polycarboxylates may be
hydrocarbyl polycarboxylates as disclosed in U.S. Patent 4,957,704, herein
incorporated by
reference.
Additional materials which may be combined with the tetrazolium compounds of
the
present invention include alkyl hydroxycarboxylic acids or a mixture of such
alkyl
hydroxycarboxylic acids having the formula:
HOOC -(Rs~)a ( Raz)b (Rs3)~ - Rsa
where a, b, and c are integers from 0 to 6 and (a+b+c)>0 where RB,, RBZ, RB3
comprise C=O or
CYZ, where Y and Z are separately selected from the group of H, OH, CHO, COOH,
CH3,
CHz(OH), CH(OH)z, CHz(COOH), CH(OH)COOH, CHz(CHO) and CH(OH)CHO, so selected
that the molecule has a minimum of one OH group when written in its fully
hydrated form and RB4
is either H or COOH, including the various stereoisomers and chemically
equivalent cyclic,
dehydrated, and hydrated forms of these acids and hydrolyzable esters and
acetals that form the
above compounds in water or the water soluble salts of such alkyl
hydroxycarboxylic acids.
Examples of such hydroxycarboxylic acids include tartaric acid, mesotartaric
acid, citric acid,
gluconic acid, glucoheptonic acid, ketomalonic acid and saccharic acid, and
their water soluble
salts.
Additional materials which may be combined with tetrazolium compounds include
aminohydroxysuccinic acid compounds (or mixtures of such aminohydroxysuccinic
acid
compounds) such as those disclosed in U.S. Patent 5,183,590, herein
incorporated by reference.
Suitable aminohydroxysuccinic acids include those selected from the group
consisting of
compounds of the generalized formulas:
ci
R N COZH
cz
HO ~COZH
_g_


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
wherein Rc, is H or C, to C4 alkyl, optionally substituted with -OH, -COZH, -
S03H, or
phenyl, C4 to C, cycloalkyl, or phenyl which is optionally substituted with -
OH or -COZH, and
R~2 is H, C, to C6 alkyl, optionally substituted with -OH or -COZH
(specifically including the
moiety -CH(COZH)CH(OH)(COZH)) ; and
~2 ~2
HOZC N Zc N C02H
HOZC ~OH HO COZH
wherein R~z is as above, and Z~ is selected from the group consisting of i)
(CHz)k wherein k is
an integer from 2 to 10, ii) -(CHz)z Xc-(CHZ)2 wherein Xc is -O-, -S-, NR~3 ,
wherein R~3 is selected from the group consisting of H, C1 to C6 alkyl,
hydroxyalkyl,
carboxyalkyl, acyl, -C(O)OR~4 wherein Rc4 is selected from the group
consisting of C, to C6
alkyl or benzyl and a residue having the general formula:
Rcz
CHZCH2 N C02H
HO COZH
wherein R~2 is as above,
iii) a residue having the generalized formula:
Y
P
- (CH2)m
~ (CH2)m
wherein Y is H, C, to C6 alkyl, alkoxy, halogen, - COzH, - S03H, m is
independently 0 or 1,
and p is 1 or 2, and
(iv) a residue having the generalized formula:
-9-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
(Q)s
(CHZ)q
(CRc5Rc6)t
(CHZ)r (CRCSRC6)t
wherein R~5 and R~6 are independently H or C, to C6 alkyl, Q is H or C1 to C6
alkyl, s is 0, 1 or 2,
t is independently 0, 1, 2, or 3, q is 0, l, 2, or 3, and r is 1 or 2 or water
soluble salts thereof.
Preferred examples of such aminohydroxysuccinic acid compounds include
iminodi(2-
hydroxysuccinic acid), N,N'-Bis(2-hydroxysuccinyl)-1,6-hexanediamine, and N,N'-
Bis(2-
hydroxysuccinyl)-m-xylylenediamine, or the water soluble salts thereof. It is
preferred to utilize
a mixture of orthophosphric acid or its water soluble salts with a least one
aminohydroxysuccinic
acid.
Additional materials which may be combined with the tetrazolium compounds
include the
carboxyamine compounds which are reaction products of carboxylating agents
such as
epoxysuccinic acid with amines comprising a plurality of nitrogen atoms such
as polyethylene
1 S polyamines as disclosed in the International Patent Application WO
96/33953, herein incorporated
by reference.
Additional materials which may be combined with the tetrazolium compounds
include
polyepoxysuccinic acids (referred to as PESAs) of the general formula:
RT RT
HO -~ C C O ~-- H
I
MT02C COZMT
where 1 ranges from about 2 to about S0, preferably 2 to 25; MT is hydrogen or
a water soluble
cation such as Na+, NH4+, or K+ and Rr is hydrogen, C1_4 alkyl or C,_4
substituted alkyl (preferably
RT is hydrogen). Preferably RT is hydrogen, and 1 ranges from about 2 to about
10, or from about
4 to about 7. The use of PESAs in treating aqueous systems has been disclosed
in U.S. Patents
5,062,962 and 5,344,590, each herein incorporated by reference. A corrosion
inhibition process
utilizing a combination of an orthophosphate, a polyepoxysuccinic acid, an
acrylic acid/allyl
hydroxy propyl sulfonic acid polymer, and an azole has been disclosed in U.S.
Patent 5,256,332,
-10-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
herein incorporated by reference. Preferred mixture include a mixture of
orthophosphoric acid
and/or its water soluble salts and polyepoxysuccinic acid.
Modified polyepoxysuccinic acids of the general formula:
RDZ RD3
RDA ZD--j-C C O~H
a f
MDOZC COZMD
wherein RD,, when present, is H, a substituted or non-substituted alkyl or
aryl moiety
having a carbon chain up to the length where solubility in aqueous solution is
lost, or a repeat unit
obtained after polymerization of an ethylenically unsaturated compound; RDZ
and RD3 each
independently are H, C~ to C4 alkyl or CI to C4 substituted alkyl; ZD is O, S,
NH, or NRD,, where
RDl is as described above, a is a positive integer greater than l; f is a
positive integer; and MD is
H, a water soluble cation (e.g., NH4+, alkali metal), or a non-substituted
lower alkyl group having
from 1 to 3 carbon atoms (when RDA is not present, ZD may be MD03S, where MD
is as described
above) may also be effectively combined with the tetrazolium compounds of the
present invention.
Use of such compounds have been disclosed in U.S. Patents 5,871,691 and
5,489,666, herein
incorporated by reference. Examples of such modified polyepoxysuccinic acids
include
derivatives according to the above formula where RD, is meta-CHZ-C6H4-CHZ- (m-
Xylylene), ZD
is -NH-, both RDZ and RD3 are H, f is 2, and MD is Na or H. Practical examples
are typically
mixtures where the individual molecules have a range of u, and are hereafter
referred to as m-
Xylylenediamine/PESA derivatives.
Additional compounds that may be combined with the tetrazolium compounds
include 2,3-
dihydroxybenzoic acid and 1,10-phenanthroline.
Additional compounds that may be combined with the tetrazolium compounds
include
monophosphonic acids having the generalized formula:
II/OH
RF P
OOH
-11-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
wherein RF is a C~ to C~Z straight or branched chain alkyl residue , a CZ to
C~2 straight or branched
chain alkenyl residue, a CS to C1z cycloalkyl residue, a C~ to Coo aryl
residue, or a C~ to C,2 aralkyl
residue, and where RF may additionally be singly or multiply substituted with
groups
independently chosen from hydroxyl, amino, or halogen; and diphosphonic acid
compounds
having the generalized formula:
HO~II II/OH
P RK P
HO ~ OH
wherein RK is a C, to C12 straight or branched chain alkylene residue, a C Z
to C l2 straight or
branched chain alkenylene residue, a CS to C,Z cycloalkylene residue, a C6 to
C,o arylene residue,
or a C~ to C~2 aralkylene residue where RK may additionally be singly or
multiply substituted with
groups independently chosen from hydroxyl, amino, or halogen, or water soluble
salts thereof.
A preferred example of such a diphosphonic acid is 1-hydroxyethane-l,l-
diphosphonic acid
(HEDP) or water soluble salts thereof.
Additional materials which may be combined with the tetrazolium compounds
include
phosphonocarboxylic acids (or mixtures of such phosphonocarboxylic acids) such
as those
disclosed in U.S. Patents 3,886,204, 3,886,205, 3,923,876, 3,933,427,
4,020,101 and 4,246,103,
all herein incorporated by reference. Preferred are those phosphonocarboxylic
acids defined by
the following generalized formulas:
HO~
P C COOH
HO CHZ COOH
and
O H
HO ~ ~I
/ P H C COOH
HO
CHZ COOH
-12-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
where RH1 is H, alkyl, alkenyl, or alkinyl radical having 1 to 4 carbon atoms,
an aryl, cycloalkyl,
or aralkyl radical, or the radical selected from the following:
RHZ RHZ CH3
CH CHZ COOH and CH CH COOH
where R~ is H, alkyl radical of 1 to 4 carbon atoms, or a carboxyl radical;
and X~, is selected from
the following:
COOH ~H P03H2 COOH P03Hz
- ~ ~ , - ~ ~ CH ~ C ~ and C-
~3 ~3
and where the -P03Hz group is the phosphono group
II/OH
P
~ OH
or water-soluble salts thereof. An example of such a preferred
phosphonocarboxylic acid is 2-
phosphonobutane-1,2,4-tricarboxylic acid, or water soluble salts thereof.
Additional materials which may be combined with the tetrazolium compounds
include
hydroxyphosphonocarboxylic acids (or mixtures of such
hydroxyphosphonocarboxylic
compounds) such as those disclosed in U.S. Patents 4,689,200 and 4,847,017,
both herein
incorporated by reference. Suitable hydroxyphosphonocarboxylic acids includes
those having the
generalized formula:
-13-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
HO ~ II
P C XE COOH
Hod I
OH
S wherein RE is H, a C, to C,Z straight or branched chain alkyl residue, a Cz
to C ,z straight or
branched chain alkenyl residue, a CS to C,Z cycloalkyl residue, a C6 to Clo
aryl residue, or a C~ to
C,Z aralkyl residue, XE is an optional group, which when present is a CI to
CIO straight or branched
chain alkylene residue, a CZ to C,o straight or branched chain alkenylene
residue, or a C6 to Clo
arylene residue or water soluble salts thereof. A preferred example of such a
hydroxyphosphonocarboxylic acid is 2-hydroxy-phosphonoacetic acid, or water
soluble salts
thereof.
Additional materials which may be combined with the tetrazolium compounds
include
aminophosphonic acids such as those disclosed in U.S. Patents 3,619,427,
3,723,347, 3,816,333,
4,029,696, 4,033,896, 4,079,006, 4,163,733, 4,307,038, 4,308,147 and
4,617,129, all herein
incorporated by reference. Suitable aminophosphonic acids include those having
the generalized
formula:
RG\ I I / off
RGZ P~
OH
4
where RGZ is a lower alkylene having from about one to about four carbon
atoms, or an amine,
hydroxy, or halogen substituted lower alkylene; R~3 is R~Z P03H2, H, OH,
amino, substituted
amino, or RF as previously defined; R~4 is R~3 or the group represented by the
generalized formula:
GS O
OH
C N RGz
OH
RG6 V RG7 W
where R~5 and R~6 are each independently chosen from H, OH, amino, substituted
amino, or RF
as previously defined; RG~ is RGS, R~6, or the group RGZ P03Hz with R~Z as
previously defined;
- 14-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
v is an integer from 1 to about 15; and w is an integer from 1 through about
14 or water soluble
salts thereof. An example of such an aminophosphonic acid is
diethylenetriamine
penta(methylenephosphonic acid), or water soluble salts thereof.
Additional materials which may be combined with the tetrazolium compounds
include
water soluble phosphonomethyl amine oxides (or mixtures of such water soluble
phosphonomethyl amine oxides) such as those disclosed in U.S. Patents
5,051,532, 5,096,595, and
5,167,866, all herein incorporated by reference. Suitable phosphonomethyl
amine oxides include
those having the generalized formula:
RA' O
N CHzPQ3Hz
RA2
wherein either RA, is selected from the group consisting of hydrocarbyl, and
hydroxy-substituted,
alkoxy-substituted, carboxyl-substituted and sulfonyl-substituted hydrocarbyl;
and R,~ is selected
from the group consisting of hydrocarbyl, and hydroxy-substituted, alkoxy-
substituted, carboxyl-
substituted and sulfonyl-substituted hydrocarbyl, CHZP03H2, and
O
GzHa N ( ~zP~Hz) z '
or RAE and R,~ together form an alicyclic ring having 3 to 5 carbon atoms in
the ring or a water
soluble salt of said phosphonomethyl amine oxide. Hydrocarbyl includes alkyl,
aryl, and alkaryl
groups which do not render the amine oxide insoluble in water. A preferred
example of such a
phosphonomethylamine oxide is N,N-bis-phosphonomethylethanolamine N-oxide,
hereafter
referred to as EBO, or water soluble salts thereof.
Additional materials which may be combined with the tetrazolium compounds
include
polymeric amine oxides as described in U.S. Patent 5,629,385, herein
incorporated by reference,
polyether polyaminomethylene phosphonates and polyether polyamino methylene
phosphonate
N-oxides, as described in U.S. Patents 5,338,477 and 5,322,636, respectively,
both herein
incorporated by reference, and iminoalkylenephosphonic acids, as described in
U.S. Patent
5,788,857, herein incorporated by reference.
-15-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Additional materials which may be combined with the tetrazolium compounds
include
phosphorus-containing carboxylate materials (hereafter, P-carboxylates) which
are telomeric, co-
telomeric, polymeric or co-polymeric compounds that include at least one
organic phosphorus
group and multiple carboxylate groups. Optionally, these materials may also
include other
substituent groups when the P-carboxylates are produced from monomers which
contain
substituents other than carboxylate. The phosphorus may be present as an end
group, in which case
it may be a phosphono or end-type phosphino-type moiety, or may be
incorporated into the
compound as a phosphino moiety in which the phosphorus is directly bonded to
two carbon atoms,
a configuration sometimes referred to as a "dialkyl" phosphino moiety. These
possibilities are
shown schematically below .
O O O
Y O PI C ~r H IP C ~. ~~ C IP C ",
O O
X X X
PHOSPHONO END-TYPE PHOSPHINO DIALKYL-TYPE
PHOSPHINO
X may be hydrogen or a cationic species such as an alkali metal ion, an
ammonium ion,
or a quaternized amine radical. Y may be the same as X or additionally may be
a substituted or
non-substituted alkyl, aryl, or alkylaryl residue, where the substitutions may
or may not contain
carboxylate. Y must be chosen so as to maintain adequate solubility of the
compound in water.
The carbon atoms shown are part of the carbon backbone of the telomer, co-
telomer, polymer, or
co-polymer, this backbone containing at least two carboxyl groups and
optionally other
phosphorus incorporations and optionally other non-carboxyl substitutions.
Preferred are P-carboxylates having number average molecular weights under
10,000, and
particularly preferred are oligomeric or polymeric P-carboxylates of low
number average
molecular weight, e.g., 2,000 or less, and especially 1,000 or less. It is
particularly preferred that
2 or more carboxylates are substituted on a linear alkyl residue, in order of
preference, in a 1,2-
(adjacent) or a 1,3-substitution arrangement. The P-carboxylates may contain
the phosphorus
substitution or substitutions predominantly or exclusively as phosphono
species, predominantly
or exclusively as end-type phosphino species, predominantly or exclusively as
dialkylphosphino
- 16-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
species, or contain a mixture of these substitution types on an individual
molecule and/or in the
mixture of molecules generated by a particular preparative process. The
various preparative
processes used for P-carboxylates may also generate various inorganic
phosphorus species as part
of the synthetic process. Such mixtures of P-carboxylates and the associated
inorganic phosphorus
species when combined with tetrazolium compounds are considered to be within
the scope of this
invention.
Non-limiting examples of the preparation of P-carboxylates suitable for use in
this
invention and their use as corrosion and/or scale control agents alone and in
combination with
other water treatment agents in aqueous systems are disclosed in U.S. patents
2,957,931,
4,046,707, 4,088,678, 4,105,551, 4,127,483, 4,159,946, 4,207,405, 4,239,648,
4,563,284,
4,621,127, 4,681,686, 5,023,000, 5,073,299, 5,077,361, 5,085,794, 5,160,630,
5,216,099,
5,229,030, 5,256,302, 5,256,746, 5,294,687, 5,360,550, 5,376,731, 5,386,038,
5,409,571,
5,606,105, 5,647,995, 5,681,479, and 5,783,728 and European Patents 283191A2,
360746B1,
569731A2, 681995A3, 786018A1, 792890A1, 807635A1, 807654A2, and 861846A2, all
herein
incorporated by reference. As may be appreciated by examination of these
patents, a variety of
preparative processes are suitable for producing P-carboxylates useful for
this invention. It is not
the object of this invention to specify any particular process or method for
making the P-
carboxylates suitable for use in this invention. In general, they may be
produced by reacting a
phosphorus containing material with one or more polymerizable monomers, at
least one of which
contains carboxyl groups or groups which can be made to generate a carboxyl in
the final
compound (after the polymerization process) by further reactions such as
hydrolysis, oxidation,
and the like, such monomers being hereafter referred to as carboxyl monomers.
The processes
disclosed in the art typically involve reaction of a phosphorus-containing
material with one or
more unsaturated monomers, at least one of which is a carboxyl monomer, to
generate P-
carboxylate oligomers or polymers. Examples of suitable carboxyl monomers
include acrylic acid,
malefic acid, malefic anhydride, methacrylic acid, itaconic acid, crotonic
acid, vinyl acetic acid,
fumaric acid, citraconic acid, mesaconic acid, acrylonitrile,
methacrylonitrile, alpha-methylene
glutaric acid, cyclohexenedicarboxylic acid, cis-1,2,3,6-tetrahydrophthalic
anhydride, 3,6-epoxy-
1,2,3,6-tetrahydrophthalic anhydride, 5-norbornene-2,3-dicarboxylic anhydride,
bicyclo[2.2.2)-5-
octene-2,3-dicarboxylic anhydride, 3-methyl-1,2,6-tetrahydrophthalic
anhydride, and 2-methyl-
1,3,6-tetrahydrophthalic anhydride. Preferred carboxyl monomers are acrylic
acid, malefic acid,
itaconic acid, and malefic anhydride.
-17-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Although it is preferred that P-carboxylate materials contain a major
proportion of residues
that bear carboxyl groups, it may be advantageous to utilize co-oligomeric or
co-polymeric P-
carboxylates that contain residues that are derived from at least one carboxyl
monomer and a
minor proportion (under SO percent by weight of the total product) of residues
obtained from at
least one other monomer that is not a carboxyl monomer. A wide variety of
suitable non-carboxyl
monomers exist, including, for example, 2-acrylamido-2-methylpropanesulfonic
acid
(commercially available as AMPSTM from the Lubrizol Corporation), 2-hydroxy-3-
(2-
propenyloxy)propanesulfonic acid, 2-methyl-2-propene-1-sulfonic acid,
allylsulfonic acid,
allyloxybenzenesulfonic acid, styrenesulfonic acid, vinylsulfonic acid,
allylphosphonic acid,
vinylphosphonic acid, isopropenylphosphonic acid, phosphoethyl methacrylate,
hydroxyalkyl and
C,-C4 alkyl esters of acrylic or methacrylic acid, acrylamides, alkyl
substituted acrylamides, allyl
alcohol, 2-vinyl pyridine, 4-vinyl pyridine, N-vinylpyrrolidone, N-
vinylformamide, N-
vinylimidazole, vinyl acetate, hydrolyzed vinyl acetate, and styrene.
Specifically included within the category of P-carboxylates are phosphonic
polymers
having the generalized formula:
II /Ox,
RJ ~ P
~OXJ
wherein X~ is H, an alkali metal atom, an alkaline earth metal atom, or an
ammonium or amine
residue; and R~~ is a copolymer residue comprising two different residues
-E- CH2 CH (R~2) -~-
wherein z is an integer ranging from 2 to 100, and wherein, in the first
residue, RJZ is -COOH, and
in the second residue, RJZ is -CONHC(CH3)ZCHZSO3XJ, wherein Xf is as
hereinbefore defined.
Non-limiting examples of P-carboxylate materials suitable for use in this
invention include
Belsperse 161, Belclene 400, Belclene 494. Belclene 500 (all commercially
available products of
FMC corporation), phosphonosuccinic acid, and Bricorr 288 (a product of
Albright and Wilson).
Bricorr 288 is described as a composition which consists essentially of up to
50% by weight of
a phosphonosuccinic acid, based on the weight of the composition, a
phosphonated dimer of alkali
metal maleate, not more than a minor proportion by weight, based on the weight
of the dimer, of
-18-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
higher phosphonated oligomers of maleate; and from about 0.5 to about 5% by
weight of the
composition of an alkali metal phosphate.
Additional materials which may be combined with the tetrazolium compounds
include
long chain fatty acid derivatives of sarcosine (or mixture of such fatty acid
sarcosine derivatives)
or their water soluble salts. An example of such a derivative is N-
Lauroylsarcosine.
The tetrazolium compounds of this invention may also be combined with water
soluble
alkali metal silicates, such as sodium metasilicate. Such silicates are well
known in the art as
corrosion inhibitors for both ferrous metals and aluminum, both in systems
where the fluid is
predominantly water as well as in glycol-based aqueous systems typically used
as antifreeze
coolants for internal combustion engines. The sodium silicates may be
represented generically
by the formula NazO~xSi02~yHzO where x is in the range of about 1 to about
3.5. Commercial
sodium silicate solutions in which the mole ratio of silica to soda is about
3.3 may be used. More
alkaline solutions having an Si02: Na20 mole ratio as low as about 1:1 or less
alkaline solutions
having a an SiOz:NazO mole ratio up to about 3.5:1 can also be used. Other
alkali metal silicate
salts, especially potassium silicate may also be employed. When using water
soluble alkali metal
silicates in the practice of the current invention, it may be advantageous to
combine the silicates
with other inhibitors and/or silica stabilizers. Examples of such suitable
combinations are
disclosed in U.S. Patents 3,711,246, 4,085,063, 4,404,114, 5,137,657,
5,262,078, 5,578,246, and
5,589,106, all herein incorporated by reference.
The tetrazolium compounds of this inventions may also be combined with water
soluble
monofluorophosphate salts. The use of such salts as corrosion inhibitors for
metallic surfaces has
been disclosed in U.S. Patents 4,132,572 and 4,613,450, both herein
incorporated by reference.
As disclosed in U.S. Patent 5,182,028, herein incorporated by reference, such
salts also have
utility for calcium carbonate scale control and in iron and manganese
stabilization.
A wide variety of additional aqueous system corrosion inhibitors suitable for
combination
with the tetrazolium materials in this invention are known in the art. Non-
limiting examples of
such inhibitors may be found in Corrosion Inhibitors, C.C. Nathan, ed., NACE,
1973; LL.
Rozenfeld, Corrosion Inhibitors, McGraw-Hill, 1981; Metals Handbook, 9''' Ed.,
Vol. 13 -
Con osion, pp. 478-497; Con osion Inhibitors for Corrosion Control, B.G.
Clubley, ed., The Royal
Society of Chemistry, 1990; Corrosion Inhibitors, European Federation of
Corrosion Publications
Number 11, The Institute of Materials, 1994; Corrosion, Vol. 2 - Corrosion
Control, L.L. Sheir,
R.A. Jarman, and G.T. Burstein, eds., Butterworth-Heinemann, 1994, pp. 17:10-
17:39; Y.I.
-19-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Kuznetsov, Organic Inhibitors of Corrosion of Metals, Plenum, 1996; and in
V.S. Sastri,
Corrosion Inhibitors: Principles and Applications, Wiley, 1998. Such
inhibitors include amines
(e.g., morpholine, cyclohexylamine, benzylamine), alkanolamines, ether amines,
diamines, fatty
amines and diamines, quaternized amines, oxyalkylated amines, alkyl pyridines;
tetrazoles such
as those disclosed in U.S. patent 5,744,069, herein incorporated by reference;
imidazoline and
substituted imidazolines, amidoamines, polyamines, including
polyalkylenepolyamines such as
those disclosed in U.S. patent 5,275,744, herein incorporated by reference,
alkyl derivatives of
benzene sulfonic acid, benzoates and substituted benzoates (e.g., p-tert-
butylbenzoic acid as
disclosed in U.S. patent 5,275,744, herein incorporated by reference),
aminobenzoates, salicylates,
dimer-trimer acids, petroleum oxidates, borogluconates; lignins, tannins, and
the sulfonated and/or
carboxylated derivatives thereof (e.g., lignosulfonates); straight chain CS-C,
~ monocarboxylates,
amine salts of carboxylic acids and mercaptocarboxylic acids such as those
disclosed in U.S.
Patent 5,779,938, herein incorporated by reference; amino acids, polyamino
acids, and derivatives
thereof such as those disclosed in U.S. Patents 4,971,724, 5,531,934,
5,616,544, 5,750,070, and
5,785,896 herein incorporated by reference; hydroxyether acids and related
lactone compounds
such as those disclosed in U.S. Patent 5,055,230 herein incorporated by
reference, N-acyl
sarcosines, N-acyliminodiacetic acids; triazine di- and tri-carboxylic acids
such as those disclosed
in U.S. 4,402,907, herein incorporated by reference, and phospho- and
phosphate esters (e.g., of
ethoxylated alcohols) such as those disclosed in U.S. Patents 3,873,465,
3,932,303, 4,066,398, and
5,611,991, herein incorporated by reference.
In the practice of this invention it may be advantageous to employ additional
agents to
enhance or add additional functionality to the combinations of this invention.
Suitable additional
agents include dispersants, copper corrosion inhibitors, aluminum corrosion
inhibitors, water
soluble metal salts and their chelates, scale and deposit control agents,
sequestering agents, anti-
foams, oxidizing and non-oxidizing biocides, non-ionic and ionic freezing
point depressants, pH
adjusting agents, inert and active tracers, water insoluble and soluble
lubricants, surfactants,
calcium hardness adjusting agents, and coloring agents.
Dispersants are often needed to maintain system cleanliness when the aqueous
system
contain suspended particulate matter. A wide variety of polymeric and non-
polymeric dispersants
are known in the art which may be used in the practice of this invention.
Preferred are a) water-
soluble sulfonated polymers or copolymers obtained from the polymerization of
one or more
ethylenically unsaturated monomers, at least one of which contains sulfonate
functionality, or the
-20-


CA 02369954 2001-10-31
w0 00/66810 PCT/US00/08750
water soluble salts thereof or b) copolymers of diiosbutylene and malefic
anhydride with molecular
weights < 10,000 or the water soluble salts thereof. Particularly preferred is
about a 3:1 weight
ratio copolymer of acrylic acid and allyl hydroxy propyl sulfonate ether or
the water soluble salts
thereof.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include copper corrosion inhibitors, including heterocyclic ring type copper
inhibitors such as
azole compounds. As is well known in the art, azoles are typically used to
provide corrosion
protection for copper-based alloys. However, as is also known in the art, in
certain systems azoles
and similar heterocyclic ring type copper inhibitors additionally provide
corrosion protection for
ferrous-based metals and/or aluminum, and the use of such materials for these
purposes is
considered to be within the scope of this invention. As one skilled in the art
may readily
appreciate, the use of copper inhibitors in the practice of this invention may
enhance the
performance of the compositions of this invention in protecting a particular
metal system and/or
may extend the applicability to multi-metal systems.
Suitable azole compounds include triazoles, tetrazoles, pyrazoles, imidazoles,
isoxazoles,
oxazoles, isothiazoles, and thiazoles, all optionally substituted with alkyl,
aryl, aralkyl, alkylol,
and alkenyl radicals, including those disclosed in U.S. Patents 2,618,608,
2,742,369, and
2,941,953 and summarized in U.S. Patent 4,101,441, all herein incorporated by
reference.
Examples of suitable azoles and related heterocylic ring compounds include
benzotriazole,
tolyltriazole, alkyl or alkoxy substituted benzotriazoles wherein the
substitution occurs on the 4
or 5 position of the benzene ring, 2-mercaptobenzothiazole, 2-
mercaptobenzotriazole,1,2,3-
triazole, 4-phenyl-1,2,3-triazole, 1,2-napthotriazole, 4-nitrobenzotriazole,
pyrazole, 6-
nitroindazole, 4-benzylpyrazole, 4,5-dimethylpyrazole, 3-allylpyrazole,
imidazole, adenine,
guanine, benzimidazole, 5-methyl benzimidazole, 2-phenyl imidazole, 2-benzyl
imidazole, 4-
allylimidazole, 4-(betahydroxy ethyl)-imidazole, purine, 4-methylimidazole,
xanthine,
hypoxanthine, 2-methyl imidazole, isoxazole, benzisoxazole, 3-
mercaptobenzisoxazole, oxazole,
2-mercapto oxazole, 2-mercaptobenzoxazole, isothiazole, 3-mercaptoisothiazole,
2-
mercaptobenzisothiazole, benzisothiazole, thiazole, 2,5-dimercaptothiadiazole,
2,5-
dimercaptobenzotriazole, 5,5'-methylene-bis-benzotriazole, and 4,5,6,7-
tetrahydrobenzotriazole.
Additional suitable azoles include those disclosed in U.S. Patents 3,985,503,
4,298,568,
4,734,257, 4,744,950, 4,874,579, 5,217,686, and 5,236,626, all incorporated
herein by reference,
and 1-phenyl-5-mercaptotetrazole as disclosed in U.S. Patent 5,156,769, herein
incorporated by
-21 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
reference. Suitable azoles include mixed compositions such as a tolyltriazole
composition which
includes at least 65% of the 5-methylbenzotriazole isomer by weight as
disclosed in U.S. Patent
5,503,775, herein incorporated by reference. Particularly suitable are halogen-
tolerant azoles
which give improved corrosion performance, no objectionable odor, and reduced
biocide
consumption when halogen-based oxidizing biocides (e.g., chlorine) are used in
the aqueous
system. Non-limiting examples of such halogen-tolerant azoles are disclosed in
U.S. Patents
5,772,919, 5,863,463 and 5,863,464, herein incorporated by reference, and
include chloro-
tolyltriazole, bromotolyltriazole, mono-halo-benzotriazole, di-halo-
benzotriazole, and mixtures
of mono-halo and di-halo-benzotriazoles.
Preferred azoles are tolyltriazole, benzotriazole and halogen-tolerant azoles,
especially
chloro-tolyltriazole.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include aluminum corrosion inhibitors. Preferred are water soluble nitrate
salts, particularly
sodium nitrate, and the combination of nitrate salts with alkali metal
silicates.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include water-soluble metal salts of metals chosen from the group zinc,
manganese, aluminum,
tin, nickel, yttrium, and the rare earth metals (atomic numbers 57 to 71)
and/or organic metal
chelates of such metals, where the organic chelant is chosen to impart a
desired level of water
solubility of the metal ion. As is known in the art, such metal salts and
chelates may be utilized
to provide additional corrosion protection.
The use of zinc ions as a corrosion inhibitor is well known in the art,
especially in
combination with other water treatment agents such as phosphates,
phosphonates, P-carboxylates,
carboxylates and hydroxycarboxylates. Preferred sources of zinc ions are the
sulfate, chloride,
acetate, or nitrate zinc salts and the zincate ion obtained by dissolving zinc
oxide in base.
Particularly preferred are the sulfate and chloride salts and the zincate ion.
The use of manganese ion in water treatment in combination with
aminophosphonates and
with P-carboxylates has been disclosed in U.S. Patent 4,640,818 and in
European Patent
283191A2, respectively, both herein incorporated by reference. The use of
yttrium and cations
of the metals of the lanthanum series having atomic numbers from 57 to 71
and/or organics
chelates thereof for corrosion inhibition in aqueous systems has been
disclosed in U.S. Patents
4,749,550 and 5,130,052, both herein incorporated by reference. The preferred
lanthanum salts
-22-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
are those of lanthanum, praseodymium, and neodymium, and commercially
available materials
which contain mixtures thereof.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include scale and deposit control agents. Although many of the previously
described
combinations of this invention provide both corrosion and scale and/or deposit
control
(particularly for calcium carbonate scales), there may instances where
additional agents must be
utilized to control scaling and/or deposition for particular species (e.g.,
barium sulfate or calcium
oxalate). Agents appropriate for control of a variety of such species are
known in the art.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include sequestering agents. Such agents are needed to prevent metallic (e.g.,
iron, copper) or
alkaline earth ions from fouling the aqueous system or from interfering with
the proper
functioning of corrosion inhibitors or other agents in the system. Such
sequestering agents are
known in the art and in some cases may be selected to be effective on a
specific ion. Non-limiting
examples of suitable sequestering agents include ethylenediaminetetra(acetic
acid) nitrolotriacetic
acid, and N,N-di(2-hydroxyethyl)glycine or water soluble salts thereof.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include anti-foams. Examples of suitable anti-foaming agents include silicones
(e.g.,
polydimethylsiloxanes), distearylsebacamides, distearyladipamide and related
products derived
from ethylene oxide or propylene oxide condensations, and fatty alcohols, such
as capryl alcohols
and their ethylene oxide condensates.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include biocides. The use of biocides may be necessary to control
microbiological growth in both
the aqueous system and in the feed sources for the compositions of this
invention. Both oxidizing
and non-oxidizing biocidal agents may be utilized for these purposes. Suitable
oxidizing biocides
include at least one of chorine, hypochlorite, bromine, hypobromite, chlorine
and/or bromine
donor compounds (e.g., bromochlorohydantoin), peracetic acid, inorganic
peroxides and peroxide
generators, chlorine dioxide, and ozone. Suitable non-oxidizing biocides
include at least one of
amines, quaternary ammonium compounds (e.g., N-alkyl dimethylbenzylammonium
chloride),
2-bromo-2-nitropropane-1,3-diol, (3-bromonitrostyrene, dodecylguanidine
hydrochloride, 2,2-
dibromo-3-nitrilopropionamide, gluteraldhyde, chlorophenols, sulphur-
containing compounds
such as sulphones, methylene bis thiocyanates and carbamates, isothiazolones,
brominated
propionamides, triazines (e.g. terbuthylazine, and triazine derivatives such
as those disclosed in
- 23 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
U.S. patent 5,534,624 herein incorporated by reference), phosphonium
compounds,
organometallic compounds such as tributyl tin oxide, and mixtures of such
biocides. A preferred
non-oxidizing biocide is a mixture of (a) 2-bromo-2-nitropropane-1,3-diol
(BNPD) and (b) a
mixture of about 75% 5-chloro-2-methyl-4-isothiazolin-3-one and about 25% 2-
methyl-4-
isothiazolin-3-one, the weight ratio said BNPD (a) to said mixture (b) being
about 16:1 to about
1:1 as disclosed in U.S. Patent 4,732,905, herein incorporated by reference.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include freezing point depressants. Such agents are needed for aqueous systems
such as
refrigeration, dehumidification, and internal combustion engine coolant
systems. The depressants
may be ionic or non-ionic in nature. Non-limiting examples of suitable ionic
agents include
calcium chloride, sodium chloride, lithium bromide, and lithium chloride.
Examples of suitable
non-ionic agents are water-soluble alcohols such as ethylene glycol, propylene
glycol, ethanol,
glycerol, isopropanol, methanol, and mixtures thereof.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include pH adjusting agents. Non-limiting examples of suitable agents include
sodium hydroxide,
potassium hydroxide, lithium hydroxide, hydrochloric acid, sulfuric acid,
nitric acid, carbon
dioxide, ammonia, organic acids such as oxalic acid, alkali metal carbonates,
and alkali metal
bicarbonates.
When the compositions of this invention are used in aqueous systems that
involve moving
contact between a surface and a metal (e.g., such as encountered in systems
containing pumping
equipment or in applications involving metal machining or forming), it may be
desirable to
employ a lubricant to improve the performance of the machining operation or to
decrease wear
of the contacting and/or metal surface. Such lubricants may be water soluble
or water insoluble.
Suitable water insoluble organic lubricants such as naturally occurnng or
synthetic oils include
those disclosed in U.S. 5,716,917, herein incorporated by reference. Suitable
water soluble
lubricants include those disclosed in U.S. patents 3,720,695, 4,053,426,
4,289,636, 4,402,839,
4,425,248, 4,636,321, 4,758,359, 4,895,668, 5,401,428, 5,547,595, 5,616,544,
and 5,653,695,
herein incorporated by reference. Some lubricants (e.g., those disclosed in
U.S. patents 4,405,426
and 5,401,428, all herein incorporated by reference) may additionally impart
improved corrosion
inhibition performance to the compositions of this invention.
It may be advantageous either in the formulation of stable product containing
a mixture
of the components of this invention or in the application of the compositions
of this invention to
-24-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
a particular aqueous system (particularly those systems in which significant
proportions of
nonaqueous fluids are present) to additionally employ surfactants. Such
surfactants may be
anionic, cationic, amphoteric or non-ionic in nature and are well known in the
art. Such agents
may be added to the compositions of this invention for a variety of functions
(e.g., as emulsifiers,
dispersants, hydrotroping agents, anti-foaming agents, lubricants, corrosion
inhibitors). The
process of selecting appropriate surfactants for accomplishing a given purpose
is well known to
those skilled in the art. It is particularly desirable to utilize surface
active agents when utilizing
additives to the compositions of this invention which have limited solubility
in water (e.g., when
employing water insoluble organic lubricants or supplementary corrosion
inhibitors based on
marginally soluble materials such as fatty acid derivatives).
Additional agents that may be combined with the tetrazolium compounds of this
invention
include calcium hardness adjusting agents. It is well known in the art that
the efficacy of many
aqueous system corrosion inhibitors, particularly those commonly used to treat
open recirculating
cooling system, is dependent upon the presence of a certain minimum level of
dissolved calcium
in the water. Although the efficacy of the compositions of this invention is
somewhat independent
of dissolved calcium, it may be advantageous in the practice of this invention
to increase the
dissolved calcium concentration in the system. Non-limiting examples of
suitable calcium
hardness adjusting agents include the bicarbonate, carbonate, chloride,
sulfate, and acetate salts
of calcium as well as calcium hydroxide and calcium oxide.
Additional agents that may be combined with the tetrazolium compounds of this
invention
include coloring agents. Non-limiting examples of the use of such agents
include improving
product appearance, aiding in product identification, and serving as additives
on which automatic
feed control systems which utilize colorimetric methods can be controlled. Non-
limiting examples
of such agents include water soluble dyes.
Surprisingly, it has been found that the tetrazolium compounds combine
synergistically
with a wide range of known scale and/or corrosion inhibitors to provide
greatly increased
performance for both generalized corrosion and pitting. The combinations are
effective over a
range of calcium hardness and pH, including low hardness waters. In some
cases, a reduction of
one order of magnitude or more in the corrosion rate occurs when employing the
combination
compared to the treatment without using a tetrazolium compound, even when
keeping total active
treatment levels constant.
- 25 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
The tetrazolium compounds of this invention are known to be reducible species.
While
the mechanistic details have not been studied in depth and are not fully
understood, it is believed
that one important element of the corrosion inhibiting effect of the novel
compositions of this
invention is the reduction of the soluble tetrazolium compound to a relatively
insoluble and
S protective film at the surface of the corroding metal. The reduction may be
a mufti-step process,
and the protective film may contain several of the intermediate reduction
products. Potentially,
some of these intermediate reduction products may not be part of the
protective film, but may be
still capable of further reduction to form a corrosion-inhibiting film. Such
corrosion-inhibiting
intermediate reduction products of the tetrazolium compounds are also
considered to be within
the scope of this invention.
The protective action of the tetrazolium compound works in concert with the
protective
action of the additional water treatment agent to provide effective aqueous
system corrosion
control. In many cases the additional water treatment agent also provides
protection against water
formed scales and deposits, and for these cases, the combinations of this
invention are effective
for the control of both corrosion and scaling/deposition. The additional water
treatment agent may
impart other desirable properties to the composition (e.g., the ability to
disperse particulate
matter). However, it is possible for certain water treatment agents (e.g.,
oxygen scavengers) to
cause the reduction of the tetrazolium compound directly in solution, making
the tetrazolium
compound itself or potential corrosion-inhibiting intermediate reduction
products unavailable to
form a protective film at the metal surface. Consequently, water treatment
agents that
substantially reduce tetrazolium compounds in aqueous solution under the
particular conditions
of use are not suitable for use with this invention. The conditions of use
include such
considerations as the relative proportions of tetrazolium compound and the
tetrazolium-reducing
water treatment agent (e.g., the use of an amount of a reducing water
treatment agent that did not
substantially reduce the amount of tetrazolium compound present would still
fall within the scope
of this invention). The conditions of use also would include the absolute
concentrations of both
tetrazolium compounds and other species, temperature, time, the presence or
absence of additional
oxidizing and/or reducing agents or other compounds that might alter the
interaction between the
tetrazolium compound and the tetrazolium-reducing water treatment agent, the
presence or
absence of catalytic surfaces (e.g., metal surfaces), and the like. One
skilled in the art may readily
determine if a particular agent substantially reduces the tetrazolium compound
under the
conditions of use. Because the reduction products of the tetrazolium compounds
are generally
-26-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
highly colored while the parent materials are not, simple methods of making
this determination
include visual inspection and colorimetry.
Expanding upon the above, the aqueous system does not contain materials
therein that
affect the corrosion inhibition of the tetrazolium compounds so that the
tetrazolium compound
S does not inhibit corrosion. Therefore, the tetrazolium compounds should not
be substantially
reduced by the materials so that the tetrazolium compound cannot inhibit
corrosion. Moreover,
any materials that negate the corrosion inhibition and/or scaling prevention
of the terazolium
compounds and/or additional materials should preferably not be included in the
aqueous system,
or should preferably be included in amounts that would not permit the
tetrazolium compounds
from achieving their intended corrosion inhibition and/or scaling prevention.
In a preferred embodiment of the present invention, from about 0.5 to 10,000
parts per
million of a combination of a tetrazolium compound and an aqueous system
treatment material
is added to the aqueous system in need of treatment, with from about 10 to
1000 parts per million
of said combination being particularly preferred. The weight ratio of the
other aqueous system
treatment material to tetrazolium compound is preferably from about 100:1 to
1:20, with a weight
ratio of from about 20:1 to 1:1 particularly preferred.
The pH of the aqueous system in which the compositions of this invention may
be applied
ranges from about 5 to about 12. The pH is preferably in the range from about
6 to about 10.
The components of this invention may be dosed into the aqueous system at an
effective
concentration by a slug feed or by blending with the aqueous fluid as the
system is being filled.
When used to treat aqueous systems in which one or more of the treatment
components are
discharged from the system or are consumed by chemical or physical processes
within the system
and thus require replenishment to maintain treatment effectiveness (e.g., open
cooling systems),
the compositions of this invention may be fed to the system on a continuous
basis, on an
intermittent basis, or using a combination of the two (e.g., utilizing a
continuous low level feed
supplemented by slug feeds as needed). Depending upon the application, it may
be advantageous
to combine the compositions of this invention together into a single treatment
fed from one feed
supply source, or, alternatively, to separate the components into two or more
treatment sources,
each source independently being fed continuously or intermittently into the
system at a rate needed
to maintain adequate concentrations in the system. Single or multiple feed
points to the aqueous
system for each treatment source may be utilized.
-27-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
The timing and rate of treatment feed may be controlled by a variety of
methods known
in the art. One suitable method is to utilize metering pumps or other feed
system devices which
may be variously configured to feed continuously at a fixed rate, on a time
schedule, on signals
generated by other system components such as makeup or blowdown pumps, or on
signals
generated by an analog or computer-based feed control system. Non-limiting
examples of suitable
feed systems have been disclosed in U.S. Patents 4,648,043, 4,659,459,
4,897,797, 5,056,036,
5,092,739 and 5,695,092. The feed control systems may utilize signals
corresponding to the
concentration of one or more of the treatment components, to the concentration
of one or more
inert or active tracer materials added to the treatment, to the value of one
or more measures of
system performance (e.g., values obtained from corrosion rate meters, scaling
monitors, heat
transfer monitoring devices, analytical devices that detect the amount
corrosion product in the
water such as total or dissolved iron or other metal constituent, and the
like), to the value of one
or more of the physical characteristics of the system (e.g., temperature, flow
rate, conductivity),
to the value of one or more chemical characteristics of the system (e.g., pH,
calcium hardness,
redox potential, alkalinity) or to combinations of these signals to feed and
maintain levels of
treatment adequate for effective performance in a particular aqueous system.
Alternatively, it may
be advantageous in some systems to employ a controlled release (also referred
to as gradual
release or time release) delivery system for some or all the compounds of this
invention. In such
controlled release systems the material or materials to be fed are impregnated
or are otherwise
incorporated into a controlled release system matrix. Suitable controlled
release delivery systems
include those in which the matrix is exposed to the fluid in the aqueous
system or to a fluid stream
being fed to the aqueous system and the treatment components are gradually
released into the
system by the action of various processes (e.g., diffusion, dissolution,
osmotic pressure
differences) and which may further be designed to vary the release rate in
response to aqueous
fluid characteristics such as temperature, flow rate, pH, water hardness,
conductivity, and the like.
Non-limiting examples of such controlled release delivery systems have been
disclosed in U.S.
Patents 3,985,298, 4,220,153, 5,316,774, 5,364,627, and 5,391,369.
When feed systems are employed that utilize measured concentrations of
treatment or
tracer components, such concentrations may be determined by continuous, semi-
continuous, or
batch type analytical techniques including spectroscopic methods (UV, visible
emission, visible
absorption, IR, Raman, fluorescence, phosphorescence, etc.), electrochemical
methods (including
pH, ORP, and ion selective electrode measurements), chromatographic methods
(GC, LC),
- 28 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
methods that rely on antibody binding or release, chemical based
analytical/colorimetric methods
such as those commercially available from the Hach Company, and the like. A
suitable
spectrophotometric method is described in U.S. 5,242,602, herein incorporated
by reference. A
suitable method for regulating the in-system concentration of a water
treatment agent is disclosed
in U.S. 5,411,889. U.5. 5,855,791, herein incorporated by reference, discloses
suitable methods
for determining the feed rates of corrosion and fouling inhibitors based on
certain performance
monitors and system characteristics.
The tracer compounds that may optionally be employed may be compounds that
serve no
particular treatment function, referred to as inert tracers, or may be water
treatment compounds
that are also readily monitored, such treatment compounds being referred to as
active tracers.
Suitable tracers include soluble lithium salts such as lithium chloride,
transition metals such as
described in U.S. 4,966,711, herein incorporated by reference, and fluorescent
inert tracers such
as described in U.S. 4,783,314, herein incorporated by reference. Suitable
fluorescent inert
tracers include the mono-, di-, and trisulfonated naphthalenes (e.g., water
soluble salts of
naphthalene sulfonic acid or of naphthalene disulfonic acid). Suitable active
tracers include
fluorescently tagged polymers such as described in U.S. 5,171,450, herein
incorporated by
reference, and polymers containing a photo-inert, latently detectable moiety
which will absorb
light when contacted with a photoactivator, as described in U.S. 5,654,198,
herein incorporated
by reference, azole-based copper corrosion inhibitors such as tolyltriazole,
and water soluble
molybdate and tungstate salts.
Although many of the compounds combined with the tetrazolium compounds are
known
corrosion inhibitors, they are generally known to be effective only under
particular conditions of
calcium hardness and pH. For example, certain phosphonocarboxylates such as 2-
phosphono-
butane-1,2,4-tricarboxylic acid (PBTC) are generally effective as corrosion
inhibitors only at pHs
exceeding 8 and in waters containing significant calcium hardness (i.e., > 200
mg/1 as CaC03).
As will be demonstrated, combinations of PBTC with the tetrazolium compounds
are very
effective at pH 7.6 in a water containing only 100 mg/1 calcium as CaC03.
Similar results are seen
with other combinations. It is particularly advantageous in many aqueous
systems to have
treatments that are "robust" with respect to the pH and hardness of the water,
i.e., that perform
well over a wide range of these conditions.
Use of the tetrazolium compound can significantly reduce the total treatment
dosage
needed to effectively limit corrosion in the aqueous system. Many of the
combinations of the
-29-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
tetrazolium compounds are with materials that are primarily or exclusively
utilized as scale and/or
deposition inhibitors. However, the combinations are effective for both
scaling/deposition and
corrosion control.
Test Methods and Conditions
The corrosion inhibition activity of the treatments in the present invention
were evaluated
using the Beaker Corrosion Test Apparatus (BCTA). The BCTA consists of a 2
liter beaker
equipped with an air/C02 sparge, 1010 low carbon steel (LCS) coupon(s), a 1010
LCS
electrochemical probe, and a magnetic stir bar. The test solution volume was
1.9 liters. Air/COz
sparging is continuous during the test. The reference electrode and counter
electrode used in
making the electrochemical corrosion measurements are constructed of Hastelloy
C22. The
beaker is immersed in a water bath for temperature control. Electrochemical
corrosion data were
obtained periodically on the probe during the test using a polarization
resistance technique. All
tests were conducted at 120°F, using a 400 RPM stir rate. Unless
otherwise noted, the test
duration was 18 hours. Two values are reported for each test; EC(avg), the
average value of the
electrochemically measured corrosion rate during the test, and EC(18 hour),
the value of the
corrosion rate at the end of the test. The latter value is thought to be more
indicative of the longer
term corrosion rate expected.
In all tests the coupons) immersed in the beaker during the test is
photographed. For some
tests, the pit depths on the coupons are measured using a microscopic
technique (see ASTM G 46-
94, section 5.2.4). For these pit measurement tests, two coupons are used and
up to 20 pits per
coupon are measured (up to 10 per side).
Unless specifically noted otherwise, the test water contains 100 mg/1 Ca (as
CaC03), 50
mg/1 Mg (as CaC03), 100 mg/1 chloride, and 100 mg/1 sulfate. Using this water,
tests were
conducted at pHs of 8.6, 7.6, and 6.8. The corresponding "M" alkalinities at
these pHs were 110,
32, and 4 mg/1 (all as CaC03).
It is relatively difficult to control ferrous metal corrosion in this test
water. The relatively
low calcium hardness makes is difficult for inhibitors which depend on calcium
to function
effectively. The relatively high sulfate and chloride levels (for the given
calcium level) makes the
water aggressive to ferrous metals, particularly with respect to pitting
corrosion.
To prevent calcium carbonate and/or calcium phosphate deposition from
occurring during
the test, many of the tests were conducted using 5 mg/1 of a Polyepoxysuccinic
Acid (PESA) with
a degree of polymerization of about 5 and 5 mg/1 active of a copolymer of
acrylic acid and
-30-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
allylhydroxypropylsulfonate ether sodium salt (AA/AHPSE) added to the test
water. For some
tests, only 5 mg/1 of AA/AHPSE copolymer was used.
Both addition and substitution (constant inhibitor level) tests were
conducted. In former
type of test, a low level of a tetrazolium compound (2 to 5 mg/1) was added to
a second
composition. In the latter test, the second composition was reduced by a given
amount (3 to 5
mg/1) and replaced by the same amount of tetrazolium compound.
Performance Examples
Example #1
BCTA results for tests conducted at pH 8.6 are shown in Table 1. The
tetrazolium
compound utilized for these tests was NBT. Belcor 575 is
hydroxyphosphonoacetic sold by FMC.
Bricorr 288 is a mixture of phosphonosuccinic acid, the phosphonated dimer of
malefic acid,
phosphoric acid, and a minor proportion by weight of higher phosphonated
oligomers of malefic
acid sold by Albright and Wilson. bequest 2060 is diethylenetriamine
penta(methylenephosphonic acid) sold by Monsanto. Bayhibit AM is 2-
phosphonobutane-1,2,4-
tricarboxylic acid sold by Bayer. Goodrite K-752 is a polyacrylate sold by B.
F. Goodrich.
As can be seen from Table 1, in all cases except for Bricorr 288, the addition
or
substitution of low levels of NBT synergistically improves corrosion
performance. Such factors
as, e.g., particular test conditions may have contributed to the Bricorr 288
result in this case.
-31 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 1
pH 8.6
With 5 mg/1 active PESA & 5 mg/I active AA/AHPSE
mg/1 INHIBITOR mg/1 EC EC
(all as actives)NBT av 18


0 ---- 0 58 50


0 ---- 2 24 24


0 ---- 5 7.7 5.5


20 L-Tartaric 0 6.2 8.5
Acid


20 L-Tartaric 2 2.6 3.2
Acid


20 L-Tartaric 5 2.7 2.7
Acid


15 HEDP 0 2.5 2.0


10 HEDP 0 3.0 2.1


7 HEDP 3 2.2 2.2


1 S 15 Belcor 575 0 3.8 2.8


10 Belcor 575 0 5.6 4.6


7 Belcor 575 3 1.7 1.2


15 Bricorr 288 0 3.8 2.9


10 Bricorr 288 0 4.7 4.0


7 Bricorr 288 3 6.2 4.4


15 Goodrite 0 25 53
K-752


12 Goodrite 3 8.8 17
K-752


15 De uest 20600 4.0 3.2


10 De uest 20600 7.3 8.8


7 De uest 20603 3.6 2.7


15 Ba hibit 0 6.1 5.7
AM


10 Ba hibit 0 8.1 9.1
AM



Example #2
Corrosion results for tests conducted at pH 7.6 with both AA/AHPSE and PESA
present
are shown in Table 2. Results with AA/AHPSE only are shown in Table 3. In
these waters, an
EC(18) of 3 mpy or less is considered to be an acceptable corrosion rate for
most industrial
applications. In some cases shown in Table 3, the corrosion rates with the
tetrazolium compound
present are not acceptable. However, the synergistic improvement of the
combination of first
component with the tetrazolium compound is obvious, and one skilled in the art
may readily
determine both the effective total amount of inhibitor needed as well as the
relative proportions
of the tetrazolium compound and other component that are needed to obtain the
corrosion
protection needed for the application of interest.
The trends noted above for results at pH 8.6 are also seen at pH 7.6. Results
for tests with
Bricorr 288 are shown in graphical form in Figure 1 to more clearly illustrate
the synergistic
-32-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
improvement obtained by utilizing the tetrazolium compound NBT in combination
with this
material.
Example #3
Corrosion results for tests conducted at pH 6.8 are shown in
Table 2
H 7.6 with 5 mg/1 active PESActive AHPSE
and 5 mg/1 a AA/


mg/ INHIBITOR mg/1 EC EC
(all as actives) NBT av 18



0 -___ 0 67 87



0 _-__ 2 65 73


0 _-_- 5 28 32


0 __-- 5 40 36



10 Goodrite K-752 0 19 37


10 Goodrite K-752 2 27 38


10 Goodrite K-752 5 11 12


20 Goodrite K-752 0 11 11


20 Goodrite K-752 2 7.4 6.9


20 Goodrite K-752 5 1.3 0.7



20 Goodrite K-732 0 14 23


25 Goodrite K-732 0 7.4 8.0


20 Goodrite K-732 2 6.4 5.6


20 Goodrite K-732 5 0.9 0.4



20 50:50 mix of Goodrite K-7520 12 18
and K-732


20 50:50 mix of Goodrite K-7522 7.8 8.8
and K-732


20 50:50 mix of Goodrite K-7525 1.3 0.6
and K-732



25 A 0 15 17


20 A 5 1.8 1.1



25 B 0 9.4 7.7


20 B 5 2.0 1.0


25 C 0 19 19


20 C 5 1.1 0.5



5 ortho-P04 0 4.1 3.0


5 ortho-P04 2 0.9 0.3


5 ortho-P04 5 0.8 0.4



20 Bricorr 288 0 5.3 4.6


15 Bricorr 288 5 1.1 0.4



20 Bayhibit AM 0 12 8.7


15 Ba hibit AM 5 2.0 0.5


A: N, N'-bis (2-hydroxysuccinyl)-6,6-hexanediamine, as Na salt
B: iminodi(2-hydroxysuccinic acid), as Na salt
C: N,N'-bis (2-hydroxy succinyl)-m-xylenediamine, as Na salt
-33-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 3
pH 7.6 with 5 mg/1 activeA/AHPSE
A


mg/1 INHIBITOR mg/1 EC EC
(all as actives) NBT avg 18


0 ---- 3 56 63


0 ---- 5 59 58


0 ---- 10 33 19


0 ---- 15 16 11


0 ---- 20 10 5



20 Bricorr 288 0 5.6 5.5


17 Bricorr 288 3 1.8 0.4


15 Bricorr 288 5 1.6 0.4


10 Bricorr 288 10 0.7 0.2


5 Bricorr 288 15 5.8 3.2



10 Bricorr 288 5 1.9 0.7


5 Bricorr 288 5 20 16



25 PESA 0 13 18


30 PESA 0 11 13


10 PESA 5 13 12


20 PESA 5 1.8 0.8


30 PESA 5 1.0 1.0


25 Citric acid 0 14 13


30 Citric Acid 0 12 14


10 Citric Acid 5 21 16


20 Citric Acid 5 2.3 0.9


30 Citric Acid 5 1.3 0.4



30 Goodrite K-732 0 6.1 6


10 Goodrite K-732 5 9.7 10


20 Goodrite K-732 5 0.8 0.5


30 Goodrite K-732 5 0.7 0.3


25 Belclene 200 0 14 13


30 Belclene 200 0 14 12


10 Belclene 200 5 6.8 6.3


20 Belclene 200 5 1.3 0.7


30 Belclene 200 5 1.2 0.7



25 2,3-Dihydroxybenzoic 0 7.7 7.0
acid


20 2,3-Dihydroxybenzoic 5 0.97 0.49
acid



25 1,2,3,4-Butanetetracarboxylic0 12 23
acid


20 1,2,3,4-Butanetetracarboxylic5 9.3 7.5
acid



75 Sodium tetraborate (Borax)0 64 77


70 Sodium tetraborate (Borax)5 58 51



30 Nitrite (from sodium 0 59 62
nitrite)


25 Nitrite (from sodium 5 36 45
nitrite)


60 Nitrite (from sodium 0 25 41
nitrite)


55 Nitrite (from sodium 5 11 14
nitrite)



-34-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 3 - Continued
uH 7.6 with 5 mg/I active AA/AHPSE
mg/1 INHIBITOR mg/1 EC EC
(all as actives) NBT av 18


25 Mesotartaric acid 0 9.4 7.7


20 Mesotartaric acid 5 1.7 0.93



30 Gluconic acid 5 3.6 2.2



20 N-Lauroyl sarcosine 0 46 73


15 N-Lauroyl sarcosine 5 30 30



25 1,10-Phenanthroline 0 59 66


20 1,10-Phenanthroline 5 40 28



30 Belsperse 161 (oligomeric0 5.2 4.4
PAA with
hos hino rou s


25 Belsperse 161 (oligomeric5 1.1 0.31
PAA with
hos hino rou s)



30 Low mol.wt.polyacrylic 0 6.6 7.1
acid (PAA)
with phosphonic acid
end group, Na
salt


25 Low mol.wt. PAA with 5 1.7 0.84
phosphonic acid
end rou , Na salt



30 Belclene 500 (Oligomeric0 14 17
PAA with
hos hino rou )


25 Belclene 500 (Oligomeric5 2.5 0.93
PAA with
hos hino rou



30 Belclene 400 (AA:AMPS 0 11 10
with
hos hinate)


25 Belclene 400 (AA:AMPS 5 3.3 1.2
with
hos hinate)



30 Belclene 494 (AA:AMPS 0 8.3 7.7
with
hos honate end)


25 Belclene 494 (AA:AMPS 5 7.2 7.2
with
hos honate end



Polycrylates


25 Goodrite K-732 5 1.1 0.35


20 Goodrite K-752 5 1.5 0.65


30 Goodrite K-752 5 0.96 0.43


Modified Polyexpoxysuccinic
acid


25 m-Xylylenediamine/PESA 5 0.98 0.48
derivative #
1, as Na salt


25 m-Xylylenediamine/PESA 5 1.7 0.62
derivative #
2, as Na salt


25 m-Xylylenediamine/PESA 5 1.7 0.72
derivative #
3, as Na salt


25 m-Xylylenediamine/PESA 5 1.8 0.73
derivative #
4, as Na salt


35 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table
4
pH
6.8



With
5
mg/1
active
PESA
and
5
m
/1
active
AA/AHPSE



mg/1 INHIBITOR mg/1 EC EC
(all as actives)NBT avg 18



0 0 71 80


0 5 67 67



25 A 0 20 20


20 A 5 3.7 1.5



25 B 0 13 14


20 B 5 2.0 0.6



25 C 0 21 19


20 5 2.7 2.3



25 Ketomalonic acid0 6.2 5.3


20 Ketomalonic acid5 2.3 1.9



25 L-tartaric acid 0 17 17


20 L-tartaric acid 5 4.3 2.0



25 Saccharic acid 0 13 12


20 Saccharic acid 5 2.2 0.9



7 ortho-PO 0 4.5 4.1


7 ortho-P 2 1.4 1.0


7 ortho-P04 5 1.0 0.6



20 Bricorr 288 0 5.0 6.2


15 Bricorr 288 5 1.3 0.5



20 HEDP 0 7.3 5.9


15 HEDP 5 1.0 0.6



20 Belcor 575 0 5.7 8.5


15 Belcor 575 5 0.7 0.6



20 molybdate, as 0 15 33
Mo0


15 molybdate, as 5 11 12
Mo0


30 molybdate, as 0 8.1 11
Mo0


25 molybdate, as 5 2.8 3.1
Mo0



25 oodrite K-732 0 8.8 8.4



-36-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
EFFICACY AT INHIBITING GROWTH OF PITS
Example #4
Pit depth results for varying exposure times for tests at pH 8.6 with tartaric
acid are shown
in Table 5. As the results show, addition of NBT is very effective at limiting
the growth of pits.
S Pitting is a particular problem for non-phosphorus inhibitors such as
tartaric acid.
Table 5
Pit Depths as a Function of Immersion Time
20 mg/1 Tartaric Acid, pH 8.6 Test With 5 mg/1 active PESA and 5 mg/1 active
AA/AHPSE
Pit depths in microns; tabulated values are averages
ADDITIVE


Immersion None 2 mg/1 5 mg/1
(hours) NBT NBT


18 56 34 18


42 89 23 21


66 130 30 30


90 134 44 30


Example #5
Pit depth and pit count data for tests at pH 7.6 with ortho-phosphate are
shown in Table
6. These results show that NBT is effective both at reducing pit depths and
pit densities.
Table 6
Pit Depth and Count
7 mg/1 ortho-P04, pH 7.6, 18 hour test
With 5 mg/1 active PESA and 5 mg/1 active AA/AHPSE
Pit depths in microns; tabulated values are averages
ADDITIVE


None 2 mg/1 5 mg/1
NBT NBT


De th 22 11 9


Pit Count80* 39 18


* More pits existed but total pit count was not obtained
Example #6
Shown in Table 7 are pitting data obtained at 10 mg/1 total added inhibitor
which further
demonstrate the pit growth inhibiting property of NBT. Although pit densities
were higher in the
-37-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
treatments containing NBT, pit depths were significantly lower. The
significant impact of NBT
on general corrosion rate can clearly be seen in the case of Bayhibit AM.
Table 7 pH 8.6 Results
10
with 5 mg/1 Copolymer of acrylic acid/1-allyloxy-2-hydroxypropane
sulfonic acid and 5 mg/1 PESA present
PD = Pit depth measured on coupons at end of test, in microns
Max = maximum depth, Avg = average depth, Min = minimum depth
mg/1 Inhibitor mg/1 EC EC Total Max Avg Min
(as actives)NBT (avg) (18) # its PD PD PD


HEDP 0 3.0 2.1 8 48 42 40


7 HEDP 3 2.2 2.2 20 23 14 8


10 Bayhibit 0 8.1 9.1 11 82 58 38
AM


7 Bayhibit 3 3.4 3.0 20 68 30 7
AM


Additional Examples - Other Test Waters
The hardness and pH of waters in aqueous systems such as cooling towers and
the like can
vary widely. It is greatly advantageous to have inhibitor formulations which
can function
effectively over a wide hardness range and pH range while inhibiting both
corrosion and
deposition. It is of further advantage in certain systems that must use
uncycled water which
typically has low calcium (< 100 mg/1 Ca as CaC03) and is relatively neutral
pH (6.5-7.5) that the
inhibitors used need not rely on alkaline pH, high hardness conditions to
function effectively, as
is the case with many of the treatments currently in use. Examples of such
systems are closed loop
cooling systems once through cooling systems, hot water heating systems, and
the like. The
following examples further establish the wide-ranging effectiveness of
inhibitor formulations
containing a tetrazolium compound and the improvement obtained over materials
known in the
art when a tetrazolium compound is utilized in conjunction with other
components described in
this disclosure.
Example #7
Low pH, low hardness
Table 8 shows results from a water containing 15 mg/1 Ca as CaC03, 7.6 mg/1 Mg
as
CaC03, 71 mg/1 Cl, 48 mg/1504, with S mg/1 active AA/AHPSE at pH 7Ø A
significant decrease
in corrosion rate is observed when 5 mg/1 NBT is added.
-38-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 8
mg/1 Treatment mg/1EC EC
NBT avg (18)


10 O-PO 0 12 9.7


10 O-PO 5 1.2 0.67


20 Bricorr 288 0 10 9.2


20 Bricorr 288 5 0.96 0.21


20 HEDP 0 9.1 9.0


20 HEDP 5 0.89 0.13


20 Belcor 575 0 5.9 5.8


20 Belcor 575 5 0.51 0.21


15 EBO 0 14 15



30 Goodrite 0 6.1 6.4
K-732


30 Goodrite 5 0.48 0.12
K-732


60 L-Tartaric 0 13 12
acid


60 L-Tartaric 5 2.4 1.2
acid


20 Ketomalonic 0 5.3 6.3


20 Ketomalonic S 1.1 0.70


20 Saccharic 5 2.1 1.1
Acid


25
O - P04: orthophosphate
HEDP: Hydroxyethylidene diphosphonic acid
Example #8
Lower pH, higher hardness
Results of BCTA tests conducted at pH 6.8 in a water containing 500 mg/1 Ca as
CaC03,
250 mg/1 Mg as CaC03, 7 mg/1 MAIk as CaC03, 354 mg/1 chloride, and 500 mg/1
sulfate are
shown in Table 9. All tests contained 5 mg/1 active AA/AHPSE. Conditions of
this kind are often
encountered in open recirculating cooling systems where the source (makeup)
water has been
concentrated several times due to evaporation and sulfuric acid has been added
to maintain
relatively low pH. In these series of tests the total inhibitor concentration
was kept constant or
nearly constant for each pair of comparisons (with and without NBT). In each
case, replacement
of part of the inhibitor or inhibitor blend with NBT resulted in a significant
improvement in
corrosion performance. As previously noted, not all combinations with the
tetrazolium compound
provide acceptable corrosion performance, but the combination in all cases
improves performance.
One skilled in the art may readily determine the appropriate levels and ratios
needed to obtain
satisfactory performance in a particular aqueous system.
-39-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 9
mg/I Treat mg/1 Treat mg/I EC EC
#1 #2 NBT (av (18



10 O-P04 0 7.5 5.0


5 O-P 4 5 2.3 1.6



7 -P 4 3.0 P o-P 0 2.9 1.2


5.5 O-P04 2.5 P o-PO 3 0.99 0.37


2.0 P o-P 3 1.6 0.77



15 Bricorr
288
---
---
5 13
13
16 Bricorr
288
4 O-PO
0 2.6
1.6


12 Bricorr
288
3 O-PO
5 1.5
0.92



25 Saccharic--- --- 0 34 60


20 Saccharic--- --- 5 13 11



15 Saccharic4 O-PO 0 7.9 8.2


12 Saccharic3 O-PO 5 2.1 1.3



16 D 4 O-PO 0 12 7.7


T7 ~ O-P(y 5 ~ 1 _9 O_R9
~


D: imino-di(2-hydroxy succinic acid), as Na salt
Example #9
Higher pH, moderate hardness water
Table 10 shows the results from a pH 8.6 test water that contains 360 mg/1 Ca
as CaC03,
180 mg/1 Mg as CaC03, 255 mg/1 Cl, 220 mg/1 S04, and 300 mg/1 Malk as CaC03.
All tests
contain 5 mg/1 active AA/AHPSE. Conditions of this kind are often encountered
in open
recirculating cooling systems where the source (makeup) water has been
concentrated several
times due to evaporation and the pH has been controlled to be in the mid-pH 8
range to make it
easier to control ferrous corrosion. The effectiveness of the addition of a
tetrazolium compound
under these conditions is apparent from these results.
-40-


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
Table 10
mg/1 Treat mg/1 Treat mg/1 EC EC
#1 #2 NBT (av (18
)



10 PESA --- --- 0 11 15


5 PESA --- --- 5 6.7 3.3


20 PESA --- --- 0 7.6 7.0


10 PESA --- --- 5 4.5 2.7


20 PESA --- --- 5 2.5 1.7



10 PESA 10 L-Tartaric0 7.3 4.3
acid


10 PESA 10 L-Tartaric5 2.5 1.9
acid



10 AcumerTM --- --- 0 11 7.8
4210


10 AcumerTM --- --- 5 3.7 1.6
4210


20 Acumer 4210--- --- 0 6.4 4.1


20 Acumer 4210--- --- 5 2.2 2.0



10 Acumer 421010 PESA 0 6.4 4.3


10 Acumer 421010 PESA 5 2.6 2.0



10 Acumer 421010 L-Tartaric0 5.4 3.5
Acid


10 Acumer 421010 L-Tartaric5 1.9 1.6
Acid


Acumer 4210: Polymaleic acid, available from Rohm & Haas
Example #10
ADDITIONAL TETRAZOLIUM COMPOUNDS
Data obtained with NBT and three additional tetrazolium compounds: Distyryl
Nitroblue Tetrazolium Chloride (DNBT), Tetranitro Blue Tetrazolium Chloride
(TNBT), and
2-(4-lodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT) at pH
7.6 are shown in
Table 11. The test water is the same as for Example 2. Other than the DNBT
combination
with Belclene 200, the synergistic interaction of the combination of a
tetrazolium compound
with other materials disclosed in this invention is evident.
-41 -


CA 02369954 2001-10-31
WO 00/66810 PCT/US00/08750
TABLE 11
INHIBITOR mg/1 Tetrazoliummg/1EC EC
(all as actives) com ound av 18


---- ---- DNBT 25 15 13


$ ---- ---- TNBT 25 12 9.0


---- ---- INT 25 9.0 5.7


---- ---- NBT 20 10 5



Bricorr 288 25 ---- ----4.4 4.2


Bricorr 288 20 DNBT 5 1.5 0.9


Bricorr 288 20 TNBT 5 1.1 0.8


Bricorr 288 20 INT 5 4.0 3.7


Bricorr 288 15 NBT 5 1.6 0.4



Belclene 25 ---- ----15 13
200


Belclene 20 DNBT 5 21 22
200


Belclene 20 TNBT 5 5.5 5.2
200


Belclene 20 INT 5 6.7 11
200


Belclene 20 NBT 5 1.3 0.7
200


While this invention has been described with respect to particular embodiments
thereof, it is apparent that numerous other forms and modifications of this
invention will be
obvious to those skilled in the art. The appended claims and this invention
generally should be
construed to cover all such obvious forms and modifications which are within
the true spirit
and scope of the present invention.
-42-

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2000-05-02
(87) PCT Publication Date 2000-11-09
(85) National Entry 2001-10-31
Examination Requested 2002-10-29
Dead Application 2005-05-02

Abandonment History

Abandonment Date Reason Reinstatement Date
2004-05-03 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2001-10-31
Application Fee $300.00 2001-10-31
Maintenance Fee - Application - New Act 2 2002-05-02 $100.00 2002-03-21
Request for Examination $400.00 2002-10-29
Maintenance Fee - Application - New Act 3 2003-05-02 $100.00 2003-04-23
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BETZDEARBORN INC.
Past Owners on Record
CHENG, LONGCHUN
EHRHARDT, WILLIAM C.
STASNEY, DAWN
WHITAKER, KIM A.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 2002-04-23 1 3
Cover Page 2002-04-24 1 38
Claims 2001-11-02 53 2,643
Claims 2001-10-31 53 2,456
Description 2001-10-31 42 2,061
Abstract 2001-10-31 1 19
Drawings 2001-10-31 1 29
PCT 2001-10-31 66 2,932
Assignment 2001-10-31 7 171
Prosecution-Amendment 2002-10-29 1 48
Fees 2003-04-23 1 36
Fees 2002-03-21 1 41
PCT 2001-11-01 60 3,007